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Abstract 
 
Thrombospondin-1 and cd47 mediate peripheral microvascular dysfunction following 
pulmonary exposure to multi-walled carbon nanotubes 
W. Kyle Mandler 
Pulmonary exposure to multi-walled carbon nanotubes (MWCNT) has been 
shown to disrupt endothelium-dependent arteriolar dilation in the peripheral 
microcirculation. The molecular mechanisms behind these arteriolar disruptions have 
yet to be fully elucidated. The secreted matricellular matrix protein thrombospondin-1 
(TSP-1) is capable of moderating arteriolar vasodilation by inhibiting NO signaling at 
several points, including the inhibition soluble guanylate cyclase activity and eNOS 
activation. The central hypothesis was that TSP-1, following pulmonary exposure to 
MWCNT, mediates peripheral changes in dilatory capacity. To test this hypothesis, wild-
type C57B6J (WT), TSP-1 knockout (TSP-1 KO) and CD47 knockout (CD47 KO) mice 
were exposed via lung aspiration to 50 µg MWCNT or a sham dispersion medium 
control. Following exposure (24hrs), arteriolar characteristics and reactivity were 
measured in the gluteus maximus muscle using intravital microscopy (IVM) coupled 
with microiontophoretic delivery of acetylcholine (ACh) or sodium nitroprusside (SNP).  
In WT mice exposed to MWCNT, skeletal muscle TSP-1 protein increased (p < 0.05) 
517.9 ± 112.5 % compared to sham exposed, and exhibited a 38.5 ± 2.5 % and 47.9 
± 7.3 % decrease (p < 0.05) in endothelium-dependent and independent vasodilation, 
respectively.  In contrast, TSP-1 protein was not increased following MWCNT exposure 
in TSP-1 KO mice and KO were protected from losses in dilatory capacity. Microvascular 
leukocyte-endothelium interactions were measured by leukocyte adhesion and rolling 
activity in third order venules. The WT+MWCNT group demonstrated 223.8 ± 7.6 % 
higher (p < 0.05) leukocyte rolling compared to WT+SHAM controls. TSP-1 KO and 
CD47 animals exposed to MWCNT showed no differences from WT+SHAM control.  
Total tissue total nitrite (NO-2) and nitrate (NO-3) a measure of nitric oxide status, was 
decreased (p < 0.05) in WT+MWCNT lung by 47.4 ± 13.8 % and plasma by 32.3 ± 4.0 
%, while not different from sham controls in the KO groups. Finally, several 
inflammatory cytokines, as quantified by Meso Scale Discovery, were upregulated in 
tissues of both TSP-1 and CD47 KO animals, but not in either of the WT groups. Taken 
together, these data provide the first evidence that TSP-1 is likely a central mediator of 
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 Through their modulation of blood pressure and regulation of flow to the 
capillaries, the arterioles play a crucial role in the maintenance of homeostasis. 
Arteriolar influence over these hemodynamic functions is achieved primarily through 
alterations in vessel diameter, which is a product of the contractile state of the smooth 
muscle layer. The ability of the vascular smooth muscle to react to a variety of neural, 
mechanical, humoral, and electrochemical stimuli is necessary to match blood flow in 
the capillaries to local metabolic demand. One of the most important factors influencing 
arteriolar reactivity is nitric oxide (NO). Produced by the vascular endothelium, NO 
quickly diffuses out to the smooth muscle and signals for relaxation and encouraging 
blood flow. An inability to produce or respond appropriately to NO can negatively 
impact homeostasis, and is etiologically implicated in a number of critical cardiovascular 
disease states, including pulmonary arterial hypertension, atherosclerosis, and 
peripheral and coronary vascular disease.  
In addition to acute and chronic lung toxicities, pulmonary exposure to 
particulate matter, engineered nanomaterials, and especially multi-walled carbon 
nanotubes (MWCNT) have been shown to disrupt arteriolar reactivity. Evidence 
suggests that disruptions in NO production, signaling, and bioavailability play a role in 
this outcome. However, the mechanisms linking acute lung injury to peripheral changes 
in the vasculature have not yet been fully elucidated. The matricellular glycoprotein 
thrombospondin-1 (TSP-1) binding through cell surface receptors CD36 and CD47 has 
3 
 
been shown to be capable of mediating NO signaling and reactivity in the vascular 
system through alterations in eNOS and sGC activity, and is upregulated in all of the 
disease states mentioned earlier. Recent evidence has put TSP-1 signaling at the 
forefront of possible connections between pulmonary MWCNT exposure and peripheral 
microvascular dysfunction. 
The objective of this work was to determine the effects of TSP-1 on skeletal 
muscle arteriole function and its potential role in mediating microvascular dysfunction 
following pulmonary MWCNT exposure. The central hypothesis was that TSP-1, 




Specific Aim 1: Develop a mouse model of skeletal muscle intravital 
microscopy for use in pulmonary nanomaterial exposure experiments. 
 Intravital microscopy is a well-established technique for examining microvascular 
function following nanomaterial exposure, however the bulk of this research is 
conducted using rats. In order to determine the involvement of TSP-1 in microvascular 
dysfunction, KO mice must be used. Intravital microscopy of mouse gluteus maximus 
muscles has been developed in other labs, but has never been used to examine the 
arteriolar function in the context of nanomaterial exposure or in TSP-1 knockout 
animals. We hypothesize that TSP-1 knockout mouse arterioles, when examined in the 
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gluteus maximus using intravital microscopy, will have enhanced vasodilatory capacity, 
compared to WT. 
 
Specific Aim 2: Determine involvement of TSP-1 in mediating microvascular 
dysfunction following pulmonary MWNCT exposure 
 Despite the apparent involvement of TSP-1 in influencing endothelial function 
and arteriolar reactivity, the effect of ENM exposure on its expression and activity and 
subsequent cardiovascular effects have yet to be investigated. We hypothesize that 
pulmonary MWCNT exposure elevates levels of TSP-1 protein in the peripheral tissues, 
mediating systemic arteriolar endothelial dysfunction. Mice lacking the TSP-1 gene (i.e. 
knockout mice) should be protected from this effect due to the lack of TSP-1 negative 
influence on endothelial NO production. 
 
Specific Aim 3: Determine if CD47 is responsible for mediating MWCNT/TSP-
1-induced alterations in NO signaling 
CD47 is the primary TSP-1 receptor responsible for mediating changes in 
vascular reactivity, with a much higher affinity and sensitivity than CD36. In some 
studies, CD47 appears to be necessary to mediate the anti-vasodilatory effects of TSP-
1. The primary objective of this aim was to determine if CD47 is involved in mediating 
MWCNT-induced changes in peripheral vascular function. We also sought to determine 
if changes in redox status in the blood and tissues were occurring that may influence 
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this process, as well as identifying changes in potential inflammatory biomarkers. We 
hypothesize that CD47 KO animals will be protected from MWCNT-induced changes in 
the microvasculature, and that inflammatory markers will be elevated in WT animals, 
but not to the same degree as CD47 KO. 
 
Significance: 
 Pulmonary exposure to particulate matter and especially nanomaterials has been 
shown to disrupt the critically important functions of the microvasculature. Strong 
evidence suggests that a disruption of vascular nitric oxide signaling is a major 
contributor to this dysfunction, however the mechanisms responsible for mediating this 
are unclear. These data will add substantially to our understanding of the role of TSP-1 
in mediating peripheral microvascular dysfunction following pulmonary MWCNT 
exposure, and if confirmed, may offer a potential therapeutic target to prevent 
dysfunction in a variety of pathologies.  
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Consisting of the heart, arteries, arterioles, capillaries, venules, veins, and the 
blood transported therein, proper function of the cardiovascular system contributes to 
the maintenance of homeostasis in health and is a source of dysfunction in disease. 
Through constriction, the powerful ventricles of the heart propel blood through either 
the pulmonary circuit where it is oxygenated in the lungs, or through the systemic 
circuit, where gas and nutrient exchange occurs with the tissues. Delivery of nutrients 
to the tissues is determined by a combination of cardiac output and peripheral control 
of perfusion by alterations in resistance. Cardiac output is a factor of heart rate and the 
volume ejected by the ventricles during each stroke (Young, 2010).  Stroke volume may 
be influenced directly by increases in afterload caused by increased mean arterial 
pressure (MAP), defined below where CO = cardiac output, SVR = systemic vascular 
resistance, and CVP = central venous pressure: 
𝑀𝐴𝑃 = (𝐶𝑂 𝑋 𝑆𝑉𝑅) + 𝐶𝑉𝑃 
Changes in preload may also affect stroke volume through the Frank-Starling 
mechanism. Vessel diameter is a major determinant of SVR (Klabunde, 2012), this is 
evident in the equation below, where R = resistance, L = vessel length, η = blood 
viscosity, and r = vessel radius.  
𝑅 = 8𝐿η/(π𝑟4) 
Due to the 4th power relationship, vessel radius is the primary determining factor of 
resistance. Because their numerousness, small diameter, and relatively high 
muscularity, the arterioles are the greatest source of peripheral resistance in the 
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circulation. Any perturbations in the ability of the arterioles to properly regulate 
diameter can result in improper matching of blood flow to the downstream tissues 
(Joussen et al., 2004), as well as alterations in systemic pressures (Landmesser and 
Drexler, 2007).  
Of particular concern in the realm of particulate matter toxicology is the 
microvasculature or microcirculation, which is defined as the arterioles, capillaries, 
venules, and lymphatic vessels that are contained within and supply a single tissue or 
organ.  The microvasculature is responsible for supplying nutrient and gas exchange as 
well as waste removal from its host tissue and must alter the rate of blood flow to 
match metabolic demand at any given time (Klabunde, 2012). The structure of the 
arterioles, capillaries, and venules help define their function.  
 
Microvascular Anatomy 
Healthy arterioles possess an intact endothelial monolayer 0.1 to 0.5 µm thick, 
arranged longitudinally and covered on the luminal side by a thin glycocalyx (Reitsma et 
al., 2007). Each endothelial cell is bordered by an F-actin filament which helps transmit 
shear stress and mediate NO release (Fels et al., 2012). Shear stress is the force per 
unit area generated by the tangential force of the blood flow acting on the apical 
endothelial surface (Davies, 2009). Beneath the arteriolar endothelium is a basement 
membrane ~ 0.1 µm thick containing mostly type IV collagen, laminin, and 
proteoglycans (Martinez-Lemus, 2012). Surrounding the basement membrane are at 
least one layer of vascular smooth muscle cells, arranged perpendicular to the axis of 
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blood flow. Somewhat unique to the resistance vasculature, myoendothelial junctions 
(MEJ) are protrusions of the endothelial cells through the basement membrane to 
contact the VSMCs and provide a direct mechanism of communication through gap 
junctions (Dora et al., 1997, Heberlein et al., 2009). The MEJ are rich in caveolae, 
invaginations of the lipid membrane which play an important role in mobilization and 
organization of signaling proteins such as IP3 receptors, ion channels, and eNOS (Straub 
et al., 2014).  Outside of the smooth muscle is a thick layer of adventitia, composed of 
fibroblasts surrounded by and extracellular matrix composed primarily of collagen 
fibers. Nerve endings are also found embedded in the adventitia and smooth muscle. 
The arterioles are richly innervated by the sympathetic nervous system with many α1 
and α2 receptors (Segal, 2005). In most vascular beds, proceeding from a main first 
order arteriole, the arterioles branch out into smaller successive branches into 2nd, 3rd, 
4th order or until reaching the terminal arteriole immediately upstream of the capillaries. 
This branching scheme nomenclature is actually borrowed from the field of hydrology, 
where branching stream watersheds bear a striking resemblance to vascular beds 
(Strahler, 1957, Linderman and Boegehold, 1996). In the mouse gluteus maximus, as in 
most vascular beds, five branch orders can be defined by this method. In our 
observations, 1st order arteriole diameter when measured under baseline conditions in 
the mouse gluteus maximus averaged approximately 34 µm, with a maximal passive 
diameter of about 51 µm, while the larger feed arterioles tended to be about 70 µm. 1st 
order, also abbreviated as “1A,” arterioles have higher tone, reactivity, and lumen to 
wall ratio compared to other vessels in the arterial tree (Pries and Secomb, 2008).  
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At the distal end of the terminal capillary lies the precapillary sphincter, beyond 
which are many branching capillaries. In the skeletal muscle, as many as 10 – 15 
branching capillaries arise from a single terminal arteriole and run in parallel along 
skeletal muscle fibers, with occasional cross connections (Johnson, 2008). Unlike the 
arterioles, capillaries have no smooth muscle and consist mostly of an endothelium 
surrounded by basement membrane. Capillary length in skeletal muscle ranges from 
100 to 400 µm (Johnson, 2008). Capillary diameter tends to be smaller at the arterial 
side with a slight widening toward the venular side (Henquell et al., 1976). The 
arteriolar-side diameter tends to be just smaller than the erythrocytes, with a slight 
widening toward the venular side (Pries and Secomb, 2008). Capillary density can vary 
widely between tissues and between fiber types in skeletal muscle, with a trend toward 
higher density in more oxidative fibers (Qu et al., 1997). In dog gastrocnemius muscle 
it was observed that there were 260 km of capillaries, with a total area of 2m2 per 100 
g of muscle (Casley-Smith et al., 1974).  
The venules mirror the arterioles in organization, although they tend to be more 
numerous and drain the capillary network supplied by arterioles. Venular pressures are 
very low, and their diameter is significantly larger than arterioles in the same order. The 
result of low pressure and wide vessels is generally blood velocity compared to the 
arterioles. The venules in skeletal muscle tend to be poorly innervated if at all, although 
in other tissues this is not necessarily the case. Venules represent the major site for 
protein exchange and leukocyte trafficking (Granger and Senchenkova, 2010a). 
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Interestingly, vasodilatory and anti-vasodilatory cross-talk between venules and nearby 
arterioles is possible (Falcone and Bohlen, 1990).  
 
Arteriolar Function 
Owing to their distribution, anatomical size, and high smooth muscle/vessel wall 
ratio, the arterioles are uniquely positioned in the vascular anatomy to regulate blood 
flow to a greater degree than other vascular components. Flow (Q) through a single 
uniform vessel can be approximately described using Poiseuille’s equation, where r = 










∗  𝛥𝑃  
Poiseuille’s equation makes several assumptions; that the vessel is uniform and 
cylindrical, that flow is steady and laminar, and that the fluid behaves in a Newtonian 
manner. Derivation of this formula reveals that flow is linearly dependent on viscosity 
and vessel length, but dependence on the radius is to the fourth power. Thus, changes 
in arterial radius can dramatically alter resistance, which is the principal method of local 
control of blood flow (Pries and Secomb, 2008). Under normal physiologic conditions, 
the arteriolar VSMCs exist in a state of constant partial contraction. The amount of 
VSMC contraction required to maintain this state is known as vascular tone and exists 
on a continuum from 0 – 100%. Control of VSMC contraction is dependent on a 
complex integration of various neural, humoral, and chemical factors acting 
simultaneously on the endothelium and smooth muscle layers. At the most basic level, 
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the contractile state of the VSMC is dependent on the concentration of intracellular free 
calcium ions (Ca2+) and sensitivity of myosin light chain to those ions.  
 Regulation of VSMC contractile state and subsequent changes in vessel diameter 
is complex and dependent on a wide variety of factors and receptors. Synthesized from 
histidine by histidine decarboxylase, histamine stimulates hepthahelical receptors which 
activate PLC or adenylate cyclase (Hill et al., 1997). Prostanoids are lipid intermediates 
synthesized from membrane-derived arachoadonic acid by cyclooxygenases (COX) 
(Davidge, 2001). This family includes both prostaglandins and thromboxane. 
Prostanoids interact with at least four G-protein coupled receptors, each with unique 
tissue distribution and biological functions including either contraction or relaxation of 
smooth muscle (Coleman et al., 1994). Adenosine is a nucleoside formed during ATP 
metabolism and exerts direct control over VSMC contraction via binding to cell 
membrane G-protein-coupled receptors. In skeletal muscle, vasodilation is mediated by 
adenosine binding to A2 receptors, stimulating adenylate cyclase activity (Lynge and 
Hellsten, 2000). Adenosine may also block α-adrenoceptor mediated vasoconstriction 
and inhibit intrinsic tone of small arterioles (Nishigaki et al., 1991). 
One of the most important local regulators of arteriolar dilation is nitric oxide 
(NO). NO is synthesized in the vascular endothelium from L-arginine (Palmer et al., 
1988) by nitric oxide synthase (NOS). Three genes encode for distinct classes of NOS 
enzymes: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). 
eNOS is the predominant source of NO in the vascular system and influencer of vascular 
function and is localized primarily in the endothelial plasma membrane when active 
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(Forstermann et al., 1991, Hecker et al., 1994). Mice engineered to lack eNOS exhibit 
hypertension (Huang et al., 1995, Shesely et al., 1996) and impaired vasodilatory 
response to acetylcholine (Huang et al., 2000). eNOS is responsive to a wide range of 
positive and negative regulatory signals. For example, shear stress (Shen et al., 1992), 
acetylcholine (Stuehr et al., 1991), bradykinin (Busse et al., 1991), histamine can 
activate eNOS in calcium-dependent and calcium-independent pathways. Some of the 
principal pathways depending on calcium include the activation of transient receptor 
potential cation channel subfamily V member 4 (TRPV4) in response to shear stress. 
TRPV4 activation precipitates a Ca2+ influx which can directly participate in activation of 
eNOS, or open calcium-activated potassium channels, generating an efflux of K+ and 
hyperpolarization of the endothelial membrane (Mendoza et al., 2010).  
Hyperpolarization triggers voltage-gated calcium channels, resulting in further enhanced 
intracellular [Ca2+], allowing for the formation of Ca2+/calmodulin complex with eNOS 
(Busse and Mulsch, 1990). Shear stress can also activate eNOS in a calcium 
independent manner through the receptor tyrosine kinase vascular endothelium growth 
factor receptor 2 (VEGFR2) (Tzima et al., 2005), which activates the PI3K/Akt pathway, 
phosphorylating eNOS at serine1177 (Dimmeler et al., 1999, Fulton et al., 1999). ACh 
raises intracellular calcium via endothelial muscarinic receptors, whose binding activates 
generation of inositol 1,4,5 triphosphate (IP3) (Ishii and Kurachi, 2006), which in turn 
binds to receptors on the endoplasmic reticulum to release Ca2+. Acetylcholine signaling 
may also activate cyclooxygenase-mediated production of prostaglandins (Kellogg et al., 
2005). The ultimate sensor responsible for the tight association between intracellular 
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calcium and eNOS activity is the small ubiquitous protein calmodulin (CaM), which binds 
eNOS in a domain containing peptides 493-512 (Venema et al., 1996). Another binding 
protein crucial to eNOS activation is heat shock protein 90 (Hsp90). It appears that 
Hsp90 acts to both aid in cleavage from the inhibitory protein calveolin-1(Gratton et al., 
2000), but also to prevent protease degradation during translocation to the membrane 
(Averna et al., 2008) Inhibition of either Hsp90 (Garcia-Cardena et al., 1998, Takahashi 
and Mendelsohn, 2003) or CaM (Forstermann et al., 1991) dramatically reduce eNOS 
activity.  
Once generated, NO has an extremely short half-life in biologic systems; 
approximately 2 ms. in the intravascular space, and from 0.09 to 2 seconds in the 
extravascular space, depending on oxygen concentration (Thomas et al., 2001). Once 
produced by eNOS, NO rapidly diffuses out to the surrounding smooth muscle (Malinski 
et al., 1993). This diffusion is aided greatly by connexin channels present in the 
myoendothelial junctions (Figueroa et al., 2013). Upon reaching the smooth muscle, NO 
activates soluble guanylate cyclase (sGC) by binding a prosthetic heme iron moiety 
(Ignarro et al., 1986), enhancing catalytic conversion of cyclic guanosine 
monophosphate (GTP) to cyclic guanosine monophosphate (cGMP) by about 400-fold  
(Arnold et al., 1977, Katsuki et al., 1977). While sGC is primarily a receptor for NO, it 
can also be stimulated by organic nitrates and the benzimidazole derivative, YC-1 
(Nossaman et al., 2012). 
Raising smooth muscle cGMP concentration initiates relaxation through 
interaction with one of two cGMP-dependent protein groups; phosphodiesterase (PDE) 
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or cGMP-dependent kinases (cGK) (Carvajal et al., 2000). cGMP also binds to some 
cGMP-gated ion channels which are important in other signaling processes, however 
their relevance in VSMC NO signaling is unclear. The principal phosphodiesterase 
isoform responsible for mediating VSMC relaxation is type V (PDE5). cGMP binds at the 
GAF A domain (Rybalkin et al., 2003) and is degraded by its constitutive action. The 
relationship between NO signaling, PDE5, and vasodilation is readily apparent in the 
mechanism of action of the erectile dysfunction drug sildenafil, which inhibits PDE5-
cGMP degradation, enhancing NO-mediated dilation of arterial and trabecular smooth 
muscle (Corbin, 2004).  
Smooth muscle contractile status is modulated directly by intracellular [Ca2+]. 
Inositol triphosphate induces Ca2+ release from the sarcoplasmic reticulum and 
simultaneous influx of Ca2+ through various Ca-channels. Rising intracellular [Ca2+] 
increases Ca-calmodulin interaction with myosin light chain kinase (MLCK). Now 
activated, MLCK is free to phosphorylate myosin light chain at serine 19, enabling 
myosin-actin crossbridge formation, initiating contraction. Interestingly, Elevation of 
intracellular Ca2+ in the smooth muscle results in endothelial generation of NO in a 
negative feedback manner. The increasing concentration gradient drives Ca2+ through 
channels at the myoendothelial junction into the adjacent endothelium, stimulating NO 
and acting as a limit on vasoconstriction (Dora et al., 1997). 
The primary pro-vasodilatory function of cGMP is mediated through binding to 
cGKs, which are found predominantly in lung, some brain tissues, platelets, and smooth 
muscle cells. cGK is activated by cGMP binding, resulting in the phosphorylation of 
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several target proteins. Phosphorylation of several proteins by cGK results in an overall 
reduction in intracellular [Ca2+] and a reduction in calcium sensitivity of the contractile 
apparatus (Carvajal et al., 2000). cGK phosphorylation drives sequestration of Ca2+ via 
ATP-ase calcium pumps located on the surface of the sarcoplasmic reticulum (Hurwitz 
et al., 1973). Additionally, cGK phosphorylation promotes opening of Ca-sensitive K 
channels (BK) which contributes to relaxation through hyperpolarization of the plasma 
membrane, reducing Ca2+ influx via voltage-gated Ca channels. This effect and is 
inhibited by tetraethylammonium and charybdotoxin, inhibitors of K-Ca channels 
(Archer et al., 1994). Smooth muscle sensitivity to Ca2+ can also be affected by 
reducing the activity of MLCK. This is achieved by dephosphorylation through myosin 
light chain phosphatase. 
Regulation of vascular NO signaling is complex, necessary for healthy vessel 
function, and highly sensitive to disruption by intrinsic and extrinsic factors. Recently, 
growing attention has come to the effects of pulmonary exposure to particulate matter, 
especially that of fine (PM2.5, diameter less than 2.5 μm) and ultrafine (one dimension 
smaller than 100 nm) on parameters of peripheral vascular function, many of which are 
mediated by NO signaling. 
 
Intravital microscopy: a powerful tool for investigations of microvascular 
function in health and disease 
 
Intravital microscopy has been used extensively to study vascular responses 
following particulate matter exposure. Typically rats are used as the experimental 
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animal of choice. Their size and tolerance of invasive surgical procedures generally is 
conducive to successful experiments. Vascular beds explored using rats include 
spinotrapezius (Linderman and Boegehold, 1996, Nurkiewicz et al., 2004, Nurkiewicz et 
al., 2006, Nurkiewicz et al., 2008, Nurkiewicz et al., 2009), mesentery (Minarchick et al., 
2013), cremaster (Frisbee and Stepp, 2001), and uterine (Stapleton et al., 2015b). 
Unfortunately, genetically modified rat models are extremely limited and do not include 
the genes of interest for our research objectives. In order to probe molecular pathways 
of arteriolar function, mouse models are more readily available. Intravital microscopy of 
the mouse spinotrapezius has been used to study the microcirculation, but is not as 
well-tolerated by mice compared to rats in terms of survival rate and useful operational 
window (Lindner et al., 2002, Schneider et al., 2012, Guendel et al., 2013). Examination 
of the cremaster muscle microcirculation is much more common (Lindner et al., 2002, 
Bagher et al., 2011c) and has been used for transgenic studies (Bagher et al., 2011a). 
However, the cremaster muscle differs significantly from locomotor skeletal muscles. 
Electrochemically, it exhibits excessive spontaneous discharges, and the motor unit 
shape and firing frequency are distinct from other muscles. It also contains layers of 
smooth muscle interspersed between striated fibers (Kayalioglu et al., 2008). The 
cremaster is innervated by the following nerves; genito-femoral, ilio-inguinal, ilio-
hypogastric, and ilio-lumbal vessels (Grant, 1966). Intravital preparation of the 
cremaster requires ligation of the testicular artery and vein, as well as orchiectomy, 
which alters pressure and flow distributions (Bagher and Segal, 2011). With these 
physiologic differences in mind, investigations of microvascular function in locomotor 
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skeletal muscle arterioles should be considered. To date, the best preparation for this in 
mice is the gluteus maximus (Bearden et al., 2004, Bearden and Segal, 2004, Moore et 
al., 2010, Givvimani et al., 2013, Sinkler and Segal, 2014). 
 
Engineered Nanomaterials represent a novel challenge for toxicologists  
 The cardiovascular implications of pulmonary exposure to particulate matter have 
received intense scrutiny, particularly following a position paper issued by the American 
Heart Association in 2004 which established particulate matter of less than 10 µm 
(PM10) and less than 2.5 µm (PM2.5) in diameter as contributors to CVD (Brook et al., 
2004). In particular, the paper emphasized the potency of PM2.5 in this regard owing to 
its ability to deposit more readily in the deep lung, compared to larger particles. The 
paper also noted recent research investigating ultrafine particulate matter, consisting of 
materials <100 nm (0.1 μm) in diameter, although at the time these particles originated 
primarily as a byproduct of combustion processes. In the intervening years, materials 
science has advanced tremendously in the realm of intentionally fabricating particulate 
materials that fall under this ultrafine category.  
 Engineered nanomaterials (ENM) are a category of ultrafine particles generated 
industrially specifically in order to take advantage of nanoscale properties 
(strength/weight ratio, electrical conductivity) that are not necessarily present in their 
bulk counterparts. Despite not fulfilling some rather optimistic estimates of a trillion 
dollar market by 2015 (Roco, 2001), nanomaterials nonetheless represent an important 
and growing field of material and industrial science, and are increasingly being 
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incorporated in a wide variety of new materials and products. The life cycle of 
nanomaterials includes production, use in products, and disposal, with potential 
exposures occurring during each (Keller et al., 2013). As such, it is vital to fully 
understand any toxicities that arise from ENM exposure in as many varieties and 
exposure routes as is feasible. As it is the most likely route of exposure to ENM in 
workplace settings, pulmonary exposure to inhaled, instilled, or aspirated ENM has 
received the most study. Other commonly investigated routes of exposure include 
ingestion (in part as a secondary route of exposure during clearance of inhaled ENM 
and dermal (commonly investigated in the context of sun screen formulations of 
titanium dioxide (TiO2) and zinc oxide (ZnO)) (Stapleton et al., 2012b). 
 
Nanomaterial exposure elicits lung toxicity and inflammation 
Because of their unique size, ENM and especially MWCNT are capable of reaching 
the deep lung.  Pharyngeal aspiration of MWCNT results in 18%, 81.6%, and 0.6% of 
MWCNT lung burden in the airway, alveolar, and sub-plural regions, respectively 
(Mercer et al., 2010). Once introduced to the lungs, ENM can generate toxicity through 
several mechanisms including reactive oxygen species (ROS) generation/oxidative 
stress, inflammation, perturbation of phagocytosis, and DNA damage, among others 
(Nel et al., 2006). Some nanoparticles are capable of rapidly (<1 minutes) translocating 
into the circulation and depositing in organs (Nemmar et al., 2002). 
Extensive work has been done to characterize the pulmonary effects of two of 
the most common ENM, MWCNT and nano-TiO2.  A multi-laboratory evaluation of in 
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vivo mouse and rat pulmonary responses to various forms of both MWCNT and TiO2 
provides some of the best characterization of ENM lung toxicity (Bonner et al., 2013). 
The authors observed increased percentages of neutrophils in the bronchoalveolar 
lavage fluid (BALF), inflammatory lesions at alveolar duct bifurcations, and activated 
alveolar macrophages with numerous MWCNT inclusions in samples collected from 
animals exposed to both materials 1 day post-exposure. The authors noted that one of 
the TiO2 species in particular, the anatase nanobelt form, elicited more lung toxicity, 
similar to that observed in the MWCNT-exposed groups. The authors speculate that this 
enhanced toxicity was due in part to the higher ratio of length to width, known also as 
the aspect ratio, of this particular nanomaterial. It should be noted that comparisons 
between nanoparticles should incorporated differences in physical characteristics such 
as aspect ratio, surface area, or reactivity. Exposures to similar amounts of particles as 
measured by mass or particle number may result in different toxicities if one has a 
substantially different in one or more of these factors (Donaldson et al., 2011). Time-
course and exposure dose are also important factors in ENM-mediated pulmonary 
toxicity. Following single aspiration exposures of occupationally-relevant MWCNT 
aspiration doses (10, 20, 40, or 80 µg), BALF was collected from C57BL/6J mice at 1, 7, 
28 and 56 days post-exposure. Markers of inflammation peaked at 7 days post-
exposure and had mostly returned to baseline by 56 days. The authors also observed 
fibrosis and granuloma formation as soon as 7 days post exposure and persisted 
through the study period. 16 weeks of repeated MWCNT exposure (40 µg / week) in 
apolipoprotein E (ApoE)-/- mice results in BALF measurements of increased total protein, 
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lactate dehydrogenase activity, surfactant protein-D, and mucin, as well as greatly 
enhanced polymorphonuclear leukocyte counts (Han, 2016). While it is apparent that 
exposure to ENM and especially MWCNT species generates substantial pulmonary 
toxicity, there is increasing evidence for secondary toxicities occurring as well, including 
in the cardiovascular system.    
 
Pulmonary particulate matter exposure alters peripheral microvascular function. 
While there are a limited but growing number of studies investigating the effects 
of pulmonary MWCNT exposure on vascular outcomes, there exists a wider body of 
work regarding a variety of particulate matter in this context. Exposure to mountain top 
mining PM (primarily PM10) induced a 25% and 26% inhibition of endothelium 
dependent vasodilation via the calcium ionophore, A23187, in mesenteric and coronary 
arterioles, respectively (Knuckles et al., 2013). Several studies have investigated 
residual oil fly ash (ROFA) and TiO2 particle exposure effects on vascular function 
(Nurkiewicz et al., 2004, Nurkiewicz et al., 2006, Knuckles et al., 2012). Endothelium 
dependent vasodilation was measured in spinotrapezius arterioles of rats exposed to 
ROFA, TiO2, or vehicle control. The Ca2+ ionophore elicited reduced dilation in the ROFA 
and TiO2 groups, while exogenous NO stimulation via sodium nitroprusside (SNP) was 
not inhibited (Nurkiewicz et al., 2004). Microvascular constrictive response to 
phenylephrine was not altered. The authors also observed enhanced myeloperoxidase 
(MPO) containing polymorphonuclear leukocyte adhesion and rolling activity, as well as 
MPO deposition in the vessel wall. These results suggest that PM exposure results in 
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deficits in endothelial NO production and bioavailability while preserving smooth muscle 
NO sensitivity (Nurkiewicz et al., 2004, Nurkiewicz et al., 2006). In human studies, the 
effects of particulate matter exposure on arteriolar reactivity can be approximated by 
measuring blood flow during reactive hyperemia. Ultrafine particle exposure is 
correlated with decreased microvascular function in reactive hyperemic tests, as well as 
decreased lung function and increased circulating leukocytes (Olsen et al., 2014). 
Microvascular function is inversely related to ambient PM2.5 black carbon, NOx, and 
carbon monoxide and material oxidative potential (Zhang et al., 2016b).  
When similar studies were performed using nanoscale versions of TiO2, 
inhibitions of A23187-induced arteriolar dilation were observed to be of greater severity 
than in previous studies with fine particles (Nurkiewicz et al., 2008). Mechanistically 
speaking, nanoparticle exposure reduced NO bioavailability, enhanced reactive oxygen 
and nitrogen species in the vessel wall, and enhanced radical generating mechanisms to 
a greater degree than fine particles without altering smooth muscle sensitivity to NO 
(Nurkiewicz et al., 2009). Similar results were observed in the sub-pericardial arterioles 
(LeBlanc et al., 2009, LeBlanc et al., 2010).  Nano TiO2 aerosol inhalation (42.0 +/- 1.65 
µg deposition), results in impaired acetylcholine responsiveness in uterine arterioles, 
with no change in NO sensitivity. Leukocyte adhesion and rolling activity was more than 
doubled (Stapleton et al., 2015b). In a follow-up study, the progeny of pregnant dams 
exposed to TiO2 also exhibited signs of vascular dysfunction. Coronary and uterine 
arteriole responsiveness to acetylcholine was significantly blunted, while the coronary 
arterioles also demonstrated decreased sensitivity to NO during the application of 
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spermine NONOate. Mitochondrial state 3 respiration was also observed to be 
depressed in these vessels (Stapleton et al., 2015c).  
Only a handful of studies have investigated vascular response to pulmonary 
MWCNT exposure. Inhalation of aerosolized MWCNT by rats resulted in changes in 
transmural pressure and severe impairment of acetylcholine-driven endothelium-
dependent vasodilation in coronary arterioles. This impairment was maintained as long 
as 168 hrs. post-exposure. Responsiveness to exogenous NO and α-adrenergic activator 
phenylephrine remained intact (Stapleton et al., 2012a). Pulmonary exposure to 
MWCNT induced increases in circulating oxidative stress markers as well as 
procoagulant effects, with increased fibrinogen and coagulation factor VII (Luyts et al., 
2014). Exposure to single-walled carbon nanotubes (SWCNT) has been shown to 
increase mtDNA damage and alter markers of oxidative stress (Li et al., 2007). Mouse 
serum obtained from animals exposed to 10 or 40 µg MWCNT via oropharyngeal 
aspiration significantly inhibited acetylcholine responsiveness in aortic rings from naïve 
mice. Ablation of either CD36 in the aortas or matrix metallopeptidase 9 (MMP-9) in the 
exposed animals protected against this effect (Aragon et al., 2016). 
Evidence for contributions of pulmonary nanotube exposure to atherosclerosis 
progression is mixed.  A single exposure to single walled carbon nanotubes resulted in 
increases in markers of oxidative insults and mitochondrial DNA damage in c57BL/6 
mice for as long as 60 days after exposure. Chronic biweekly exposure for 8 weeks 
stimulated the progression of atherosclerosis by accelerating plaque formation in ApoE-/- 
mice fed an atherogenic diet 16 weeks of 40 µg / week MWCNT exposure in ApoE-/- 
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mice did not alter progression of atherosclerotic lesions, despite indications of lung 
toxicity (Li et al., 2007). Changes in diet do not seem to potentiate any apparent 
atherogenic effects of MWCNT exposure. 10 weeks of repeated pulmonary exposures (4 
or 40 µg / week) in ApoE-/- mice fed a western style resulted in increased in aortic arch 
thickening, suggesting artery remodeling. However, no acceleration in plaque 
progression in the aorta or brachiocephalic arteries were observed in histopathology 
sections (Christophersen et al., 2016).  
 As of yet it is unclear what factors relate the injury in the lung caused by 
exposure to nanomaterials to peripheral vascular dysfunction. Several hypotheses have 
been proposed to explain this phenomenon. Because of their extreme small size, ENM 
are capable of escaping the lung and translocating to various tissues via the circulation 
(Stapleton et al., 2012a). It is possible that direct interactions between ENM and the 
vasculature result in dysfunction. Indeed, during in vitro studies wherein vascular 
endothelial cells are incubated in solutions containing ENM, inflammation, reactive 
oxygen species generation, and NO signaling disruptions are often observed (Snyder-
Talkington et al., 2013, Cao et al., 2014). It should be noted, however, that only a small 
fraction of deposited ENM escape the lung (less than 0.001% in the case of MWCNT) 
(Porter et al, 2009). It is currently unclear what, if any, role this fraction of translocating 
ENM play in mediating microvascular dysfunction.  
Another possibility is that lung exposure to ENM alters autonomic outflow to the 
tissues, resulting in increased sympathetic activity and a pro-vasoconstrictive 
environment (Stapleton et al., 2015a). Evidence for this pathway, typically in the form 
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of heart rate variability alterations, exists in both experimental animals (Zheng et al., 
2016) and in human cohorts (Cavallari et al., 2008a, Cavallari et al., 2008b). At this 
time it is unclear whether this neural activation is the result of direct interaction of 
inhaled particles with components of the nervous system or due to indirect circulating 
factors of inflammation (Stapleton et al., 2015a).   
While it is almost certainly a combination of several factors, one likely pathway for 
microvascular dysfunction following pulmonary ENM exposure is through the spillover of 
inflammatory proteins into the blood, such as IL-6, IL-10, MMP-9, and others (Erdely et 
al., 2009). One potential mediator that is gaining attention is TSP-1. 
Thrombospondin-1 is a multifunctional protein with many vascular targets 
Part of the six-member thrombospondin family, TSP-1 is a large (~450kD) 
glycoprotein with a variety of functions (Chen et al., 2000, Lawler, 2000). First isolated 
as major component of stimulated α-granules in platelets, TSP-1 was originally 
identified as a mediator of wound healing through its ability to enhance platelet 
aggregation and stabilization (Baenzige.Nl et al., 1971). TSP-1 acts at the cell 
membrane to form complexes with cytokines and membrane proteins to regulate cell 
adhesion, signal transduction, and transcription (Fig. 2.1) (Lawler, 2000).  
 TSP-1 is a homotrimer, with each monomer joined by disulfide bonds. Each 
monomer is organized into discrete structural and functional segments; a terminal N 
terminal domain, a region of three types of repeated sequence motifs, and a globular 
terminal COOH domain (Chen et al., 2000, Lawler, 2000, Carlson et al., 2008).  
Thrombospondin-2 contains the same structural domains, while thrombospondins -3,-4, 
and -5 are homopentamers (Carlson et al., 2008). Each domain is associated with 
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regulation of distinct functions; the N-terminal domain are associated with heparin 
binding, cell attachment, spreading and migration, disruption of focal contacts, and 
migration (Elzie and Murphy-Ullrich, 2004). Type 1 repeats regulate protein and heparin 
binding, cell attachment, neurite outgrowth, tumor growth factor β (TGFβ) activation, 
as well as inhibition of proliferation and angiogenesis (Guo et al., 1997, Iruela-Arispe et 
al., 1999, Adams and Tucker, 2000). The region of Type 3 repeats is associated with 
calcium, cell binding, and apoptosis (Saumet et al., 2005), while the carboxyl terminal 
region is associated with cell attachment, VSMC chemotaxis and platelet aggregation, 
and NO signaling (Gao et al., 1996, Nesselroth et al., 2001).  
 
TSP-1 regulates smooth muscle activity through the receptor CD47 
The integrin associated protein CD47 is a receptor for the C-terminal domain of 
TSP-1 (Gao et al., 1996) containing an extracellular IgV domain, a transmembrane 
domain that crosses the membrane five times, and C-terminal tail contained in the 
cytoplasm.  The first evidence for the regulation of NO signaling by TSP-1/CD47 was 
provided when it was demonstrated that muscle tissue explants from TSP-1 knockout 
mice exhibited enhanced angiogenesis relative to WT controls (Zhou et al., 2006), and 
that this response was enhanced when exogenous L-arginine or NO donors were 
supplied (Isenberg et al., 2005a). Further evidence for the TSP/CD47 axis was provided 
by studies using peptides generated from the TSP-1 peptide sequence responsible for 
CD47-binding, located on the TSP-1 C-terminal domain, as well as recombinant proteins 
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containing the entire C-terminal domain were found to inhibit NO signaling in (Gao et 
al., 1996, Isenberg et al., 2006a). 
Activation of the TSP/CD47 signaling pathway leads to smooth muscle cell 
responses. Alteration of NO signaling by TSP-1, and thus vascular tone is achieved in 
part via inhibition of sGC activation (Fig. 2.1). Normal circulating plasma contains 100-
200pM TSP-1 (Bergseth et al., 2000) and is capable of regulating NO signaling at these 
concentrations in VSMC, in part due to a dramatic increase in sensitivity in the presence 
of NO (Isenberg et al., 2006b). 2.2nM TSP-1 inhibits the ability of classic sGC activators 
to delay thrombin-induced platelet aggregation and abrogate VSMC contraction in vitro 
(Miller et al., 2010).  Inhibition of sGC by TSP/CD47 appears to be dependent on an 
increase in cytoplasmic [Ca2+] (Ramanathan et al., 2011). Simultaneous stimulation of 
VSMCs with sGC activators and exogenous TSP-1 results in significantly reduced sGC 
activity and enhanced contraction compared to controls with sGC stimulators alone 
(Miller et al., 2010).   
The anti-sGC activity of TSP-1/CD47 observed in VSMC and VEC is preserved in 
isolated vessels and intact tissue. TSP-1 at 2.2nM is unable to mediate inhibition of 
vasodilation in CD47 KO arterial rings, while application of exogenous TSP-1 is still 
capable of mediating Ach-driven vasodilation in TSP-1 KO arterial rings (Bauer et al., 
2010). In isolated coronary arterioles from young (4 mo.) and old (24 mo.) rats, 
addition of 2.2nM of exogenous TSP-1 increased superoxide production in both groups, 
and inhibited NO mediated vasodilation by 24% in the old groups. Anti-CD47 antibody 
restored NO-dependent vasodilation and increased coronary flow reserve in left-
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ventricular myocardium (Nevitt et al., 2016). When treated with monoclonal TSP-1 
antibody or CD47-specific morpholino oligonucleotides, ischemic myocutaneous tissue 
flaps demonstrated increased blood flow, reduced necrosis, and enhanced tissue 
survival, compared to controls (Isenberg et al., 2009c). In response to challenge with 
exogenous NO, both TSP-1 KO and CD47 KO mice demonstrated greater decreases in 
blood pressure than WT, without significant differences in heart rate (Isenberg et al., 
2009b).  
TSP-1/CD47 also appear to be capable of inhibiting NO signaling in cGC-
independent pathways. TSP-1 has been shown to inhibit agonist-stimulated interactions 
between eNOS and Hsp90, thus limiting eNOS activation (Fig. 2.1). Treatment of WT 
vessels with physiologic concentrations (2.2nM) as well as the signature CD47-binding 
domain of TSP-1, E123CaG1, inhibits ACh-stimulated vasodilation. This inhibition 
persisted when the same experiments were carried out with ionomycin, a specific eNOS 
activating drug (Bauer et al., 2010). In arteries from CD47 KO mice, this effect was lost. 
In this study, CD47 KO animals also exhibited lower resting MAP, SBP, and DBP 
compared to WT mice (Bauer et al., 2010). Upon VEGFA protein binding, VEGFR2 
increases eNOS activity via phosphorylation of serine 1177 through the PI3K/Akt and 
PLCγ/AMPK pathways. TSP-1 is capable of inhibiting VEGF-VEGFR interaction by 
competitive binding, as well as directly binding to circulating VEGF and speeding its 
removal from the extracellular space (Anon, Gupta et al., 1999). TSP-1 may interact 








Figure 2.1. TSP-1 inhibits vascular NO signaling pathways.  TSP-1 C-terminal globular domain binding to 
integrin associated cell surface receptor CD47 inhibits NO signaling in a variety of pathways. CD47 
inhibits smooth muscle sGC activity, reducing intracellular cGMP concentrations and inhibiting 
relaxation. CD47 inhibits NO production by preventing HSP90 association with eNOS, causing eNOS 
uncoupling, as well as by inhibiting VEGFR-2 activation and inactivating circulating VEGF protein. CD47 
can reduce NO bioavailability by enhancing NOX1 production of superoxide. Finally, TSP-1/CD47 can 
promote platelet aggregation and leukocyte adhesion to the endothelium via ICAM-1 and VCAM-1. CD36 
constitutionally acts as a fatty acid translocase, allowing myristate to activate eNOS in an AMP-kinase 
dependent manner, TSP-1 type 1 repeat region binding inhibits this function.  
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CD47 is also capable of exerting influence on vessels through non-NO pathways. 
Some of these potential avenues was discovered by examining the role of TSP-1 in 
pulmonary arterial hypertension (PAH). PAH is associated with increased expression of 
TSP-1 and CD47, with a more than 10x increase in circulating TSP-1 in 93 patients with 
PH compared to 19 control subjects (Kaiser et al., 2016). The mechanism behind the 
association between TSP-1/CD47 and PAH is believed to have at least two main 
components (Kuebler, 2017). First, it was observed that CD47 constitutively associates 
with caveolin-1 and that TSP-1 binding disrupts this interaction, promoting eNOS 
uncoupling and superoxide production (Bauer et al., 2012). Endothelial superoxide 
anion formation and the resultant NO scavenging contributes to increased VSMC 
contraction and vasoconstriction (Grunfeld et al., 1995). The second component factor 
tying TSP-1/CD47 to PH is through endothelin-1 (ET1) activation. ET1 and the receptor 
ET1 receptor A (ETA) were observed to be increased in the lungs of mice with chronic 
hypoxia, but not in CD47 KO mice. The authors observed that CD47 appeared to exert 
control of ET1 through negative regulation of the transcription factor cMyc (Bauer et al., 
2010).  
Finally, CD47 may also contribute to alterations in NO signaling through its 
capacity to act as a regulator of platelet and leukocyte recruitment. Platelet CD47 
activation contributes to platelet adhesion and aggregation in times of inflammation. In 
VECs stimulated with TNFα, researchers were able to increase or decrease platelet 
adhesion by applying the CD47 agonist peptide 4N1K or blocking monoclonal 
antibodies, respectively (Lagadec et al., 2003). In addition to limiting the ability of 
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eNOS to generate NO, CD47 binding can cause eNOS uncoupling and production of 
superoxide through constitutive interaction with caveolin-1 (Bauer et al., 2012). 
Application of exogenous NO and/or elevation of cGMP is capable of delaying platelet 
aggregation during both times of high shear and static conditions. Supplying exogenous 
TSP-1 reverses this delay (Isenberg et al., 2008c). CD47 distributed at the apical 
endothelial surface is associated with upregulation of the intracellular (ICAM-1) and 
vascular (VCAM-1) cell adhesion molecules which promote leukocyte recruitment, 
adhesion, and diapedesis (Narizhneva et al., 2005). Cell adhesion molecule activation 
also activates NADPH oxidase-1 (NOX-1) within minutes, a necessary step of 
transmigration and a promoter of endothelial disorganization and permeability 
(DelMaschio et al., 1996, Deem and Cook-Mills, 2004). 
TSP-1/CD47 signaling is capable of regulating NADPH oxidase (NOX) activity (Fig. 
2.1). The NOX family of five enzyme complexes (NOX1-5) are a major generator of ROS 
and contribute to vascular diseases and vary in tissue distribution and activity (Cave et 
al., 2006, Brandes et al., 2010). In terms of vascular physiology, NOX1 and 2 are 
primarily sources of superoxide, while NOX4 is responsible for generating hydrogen 
peroxide (Dikalov et al., 2008). TSP-1 is capable of stimulating superoxide production in 
human VSMCs and isolated rat aortas at physiologic concentrations of TSP-1 found in 
humans with vascular disease (2.2nM) as early as 30 minutes after administration 
(Csanyi et al., 2012).  Lower concentrations associated with healthy subjects (0.22nM) 
did not elicit the same response. In cells where CD47 was suppressed with antisense 
morpholino oligonucleotides, TSP-1-stimulated superoxide production was reduced. 
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NOX1 was identified as the source of superoxide by analyzing the response of 
membrane fractions of VSMC with siRNA knockdown of NOX1. TSP-1 stimulated 
superoxide production was completely ablated in these membrane fractions. TSP-1 
stimulation generated a ~4-fold increase in superoxide production in endothelium-free 
aortic rings from WT mice compared to NOX-/- animals. Administration of NOX1 
morpholino oligonucuotides in rats resulted in enhanced vasodilation and increased 
blood flow, even when stimulated with TSP-1, compared to vehicle control. TSP-1/CD47 
activation of NOX1 appears to be dependent on surface receptor signal-regulatory 
protein-α (SIRP-α). TSP-1 at 2.2nM binds and activates SIRP-α and its downstream 
signal transducer SHP1. When SIRP-α is suppressed with siRNA, TSP-1 generated 
superoxide was significantly reduced and vasodilation enhanced (Yao et al., 2013). 
Taken together, it is apparent that TSP/CD47 signaling has wide-ranging effects 
on vascular NO production, signaling, bioavailability, as well as platelet aggregation and 
leukocyte-endothelium adhesion. 
 
TSP-1 and CD36 
While canonically recognized as the receptor associated with the antiangiogenic 
properties of TSP-1 (Audet et al., 2013), cell surface receptor CD36 may also play a role 
in the control of TSP-1 over vessel dilation. A fatty acid translocase and cholesterol 
uptake channel, CD36 is a ubiquitously expressed binding partner for second type I 
binding region of TSP-1 (Dawson et al., 1997). Like CD47, it appears that TSP-1/CD36 
signaling is capable of modulating eNOS activity. Myristic acid uptake by CD36 
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stimulates eNOS activity. This uptake is inhibited by 2.2 nM TSP-1 and other CD36 
binding peptides, preventing cGMP accumulation (Isenberg et al., 2007b). It is 
important to note, however, that CD47 sensitivity in terms of NO signaling disruption is 
an order of magnitude greater than that of CD36; the dissociation constant for TSP-
1/CD47 is 12pM (Isenberg et al., 2009a) vs. 227 ± 19 nM for CD36.  
Taken together, TSP-1 signaling through CD47 (at low concentrations), and 
through both CD47 and CD36 at higher concentrations appear to exert a profound anti-
vasodilatory effect by inhibiting NO signaling, inhibiting eNOS production of NO, and by 
stimulating ROS generation by NOX1. It should be expected then that pathologies which 
generate enhanced circulating TSP-1 expression should also be associated with deficits 
in vascular NO function.  
 
TSP-1 in disease states 
TSP-1/CD47 signaling is enhanced in many cases etiologically linked to a variety 
of cardiovascular disease states. One pathology commonly associated with TSP-1 is 
PAH. PAH is a chronic progression of increased artery pressure, right ventricular 
hypertrophy, and eventually right ventricular failure, ultimately leading to death. In 
murine models of PAH, TSP-1 is upregulated in the lung in a hypoxia-inducible factor 
(HIF)-2 alpha-dependent process. When translated to clinical models, patients with end-
stage PAH demonstrated enhanced TSP-1 and HIF-2α protein expression in the 
pulmonary vasculature (Labrousse-Arias et al., 2016). In a separate study, when 
measured in the circulation of 93 patients with PAH, TSP-1 was observed to be more 
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than 10 times higher than control (8.64 ± 1.05 nM vs. 0.64 ± 0.122 nM). Pulmonary 
artery pressure (r = -0.58), and vascular resistance (r = 0.33) also correlated with TSP-
1 concentration. Patients who were successfully treated and survived tended to have 
lower levels of TSP-1, whereas TSP-1 plasma levels above 15.9 nM was associated with 
all-cause mortality (Kaiser et al., 2016). TSP-1 KO mice exposed to reduced fraction of 
inspired oxygen (0.1) for six weeks demonstrated a resistance to development of PAH. 
TSP-1 KO mice had significantly lower right ventricular systolic pressures, reduced right 
ventricular hypertrophy, and lower right ventricular pressures in response to acute 
vasoconstriction compared to WT controls (Ochoa et al., 2010). It now appears that 
TSP-1/CD47 signaling is a major contributing factor in the development of PAH. It was 
observed by Rogers et al. that CD47 was upregulated in the lung and pulmonary 
arteries in patients with terminal PAH. CD47 KO were protected to an extent from 
development of right ventricular hypertension and increased right ventricular systolic 
pressure observed in WT animals exposed to 3 weeks of hypoxia (Rogers et al., 2017). 
The pathway ultimately linking upregulated TSP-1/CD47 signaling to PAH is still unclear, 
but evidence suggests that it is at least mediated through a constitutive interaction 
between CD47 and caveolin-1 (CAV1). CAV1 activation inhibits NO signaling, promotes 
eNOS uncoupling, and oxidative stress (Bauer et al., 2012). 
 TSP-1 is also considered a contributor to vascular dysfunction associated with 
diabetes. TSP-1 mRNA is enhanced in diabetic endothelial progenitor cells (EPCs) (Ii et 
al., 2006). When injected into diabetic and nondiabetic mice, EPC recruitment to the 
neoendothelium was reduced in both cases and associated with delayed 
36 
 
reendothelialization following vascular injury. In vitro studies with diabetic EPC 
demonstrated decreased migration and adhesion activities, as well as reduced VEGF 
and eNOS expression (Ii et al., 2006).  CD47 deficiency in endothelial cells improved 
angiogenic function and reduced endothelial cell senescence while also suppressing 
activation of cell cycle inhibitors and upregulating cell cycle promoters. Application of 
TSP-1 accelerates senescence and cell cycle arrest in a CD47-dependent manner (Gao 
et al., 2016). 
TSP-1 is upregulated by glucose and angiotensin II and is an activator of TGF-β. 
In diabetic rats, development of cardiomyopathy generated by abdominal aortic 
coarction was abrogated by the application of a peptide antagonist of TSP-1 dependent 
TGF- β activation. The progression of cardiac fibrosis was prevented and improved 
cardiac function was observed (Belmadani et al., 2007). In humans, higher plasma TSP-
1 levels are associated with diabetes and coronary artery disease. In 374 participants 
who had undergone coronary angiography, TSP-1 levels were higher in the diabetes 
and coronary artery disease group than any other group (Choi et al., 2012). 
 Obesity and metabolic syndrome also appear to be associated with TSP-1. In 
human adipose tissues and serum obtained from obese and non-obese subjects, TSP-1 
expression was found to be predominantly expressed in visceral adipose, relative to the 
subcutaneous adipose. Visceral adiposity is a hallmark of obesity and metabolic 
syndrome (Wajchenberg, 2000, Varma et al., 2008). Furthermore, TSP-1 expression 
level was associated with abdominal obesity, hyperglycemia, and hypertension (Matsuo 
et al., 2015).  Co-culture of adipocytes with macrophages enhances TSP-1 expression in 
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each cell type, while pioglitazone treatment results in a 54% decrease in adipose TSP-1 
expression (Varma et al., 2008). The link between obesity and TSP-1 may be related to 
adipokines secreted by adipose tissue during obesity and inflammation. The adipokine 
leptin is capable of regulating TSP-1 expression in JAK2/ERK/JNK-dependent 
mechanism (Chavez et al., 2012). Mice fed a high fat diet (60% fat, 20% carbohydrate) 
had significantly higher TSP-1 expression in perigonadal fat than in low fat diet controls. 
Interestingly, TSP-1 gene disruption attenuated weight gain and fat accumulation in 
both groups (Kong et al., 2013). This suggests that TSP-1 is not just a biomarker 
upregulated by obesity, but may potentiate it in a feed-forward manner.  
Vessel wall injury and proliferation and migration of VSMCs are critical in the 
etiology of atherosclerosis. TSP-1 and CD47 expression is increased in the vessel wall in 
several cardiovascular diseases including obesity, diabetes, and abdominal aortic 
aneurysm and atherosclerosis (Stenina et al., 2003, Moura et al., 2008, Liu et al., 2015, 
Kojima et al., 2016). It has become clear that TSP-1 plays an active role in atheroma 
formation by stimulating VSMC chemotaxis and proliferation; when the carboxyl-
terminal CD47-binding agonist peptide 4n1K is applied to both human and rat aortic 
smooth muscle cells, migration is stimulated. When monoclonal antibodies against CD47 
were applied, chemotaxis was specifically blocked (Wang and Frazier, 1998). 
Concentrations of 0.1 to 30 μg/mL TSP-1 were sufficient to generate concomitant 
increases in DNA synthesis and proliferation of VSMC in a serum free environment 
(Patel et al., 1997). In cultured VSMCs, the presence of TSP-1 upregulated genes in 13 
canonical pathways associated with atherosclerosis and an additional 4 related to 
38 
 
vascular disease. When combined with hyperglycemia, 53 canonical pathways were 
altered (Maier et al., 2010). It appears that TSP-1-induced VSMC migration and 
proliferation are dependent on microRNA-21. In VSMCs incubated in miR-21 inhibitor for 
20 minutes, TSP-1-induced migration was ablated and extracellular signaling kinase-1/2 
phosphorylation was enhanced (Stein et al., 2014). The statin drug Pravastatin is 
capable of inhibiting TSP-1-induced chemotaxis, while diethylenetriamine NONOate and 
SNAP impeded the statin effect (Seymour et al., 2014). Dyslipidemia, often associated 
with atherosclerotic progression (Alberti et al., 2009), is also capable of acting 
synergistically with TSP-1 to promote atheroma formation. LDL at a concentration of 
(175 µg/ml) augmented chemotaxis by 30 ± 10.4 %, while HDL at HDL (75 µg/ml) 
inhibited chemotaxis by 50.9 ± 8% in VSMCs cultured with TSP-1 (Desai et al., 2015). 
In diet-induced hypercholesteremic rabbits who had undergone intraluminal aortic 
injury, arterial wall TSP-1 was elevated 8-10 weeks later. Immunohistochemistry 
revealed that elevated TSP-1 was found in the extracellular matrix, and that hyperplasia 
was associated with levels of TSP-1 (Roth et al., 1998). TSP-1 is upregulated in human 
and experimental abdominal aortic aneurism, while monocytes/macrophages lacking 
TSP1 display reduced adhesion and migration capability. Reductions in monocyte 
adhesion/motility were returned to normal through the exogenous delivery of 
recombinant TSP-1 at a concentration of 50nM  (Liu et al., 2015). When translated from 
in vitro work to in vivo studies, the links between TSP-1 and vascular disease persist. In 
plasma collected from patients with peripheral artery disease (PAD), there is a linear 
correlation between PAD and TSP-1 concentration (Smadja et al., 2011). TSP-1 was 
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measured in 140 end stage renal disease patients and prospectively followed for 34.7 
months. TSP-1 was higher in patients with preexisting clinical evidence of 
cardiovascular diseases. Patients in the highest tertile of circulating TSP-1 levels 
experienced a 6-fold higher risk of cardiovascular mortality than those in the lowest 
tertile (Huang et al., 2015). Administration of anti-CD47 antibodies have been shown to 
restore normal efferocytosis and ameliorate atherosclerosis in several mouse models. 
This effect appears to be driven by the pro-atherosclerotic factor TNF-α (Kojima et al., 
2016). 
In summary, proper arteriolar function, and especially reactivity to NO signaling 
is vitally important for the maintenance of homeostasis. Disruption of this signaling 
cascade is etiologically linked to a variety of pathologies. Pulmonary exposure to 
particulate matter and especially nanomaterials has been shown to disrupt arteriolar 
reactivity and significant evidence supports that this is mediated in a NO-dependent 
manner. TSP-1 is capable of mediating NO production, bioavailability, and signaling at a 
variety of points through its receptors CD47 and CD36. In many diseases where 
microvascular dysfunction, NO signaling deficits, inflammation, and reactive oxygen 
stress are hallmarks, TSP-1 is upregulated and anti-TSP-1 interventions have been 
observed to reduce symptoms. Recent investigations have put TSP-1 at the forefront of 
potential mediators of microvascular dysfunction following MWCNT or other particulate 
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Chapter 3: Development of a mouse gluteus maximus intravital microscopy 







 To investigate the role TSP-1 and CD47 play in influencing microvascular 
reactivity following pulmonary MWCNT exposure, we decided to utilize an IVM 
technique to directly image intact arterioles and venules in living tissue in animals with 
genes for TSP-1 and CD47 knocked out. Typically, similar experiments are carried out in 
rats, examining the vessels of tissues including the spinotrapezius (Nurkiewicz et al., 
2009, Knuckles et al., 2012), mesentery (Knuckles et al., 2013, Minarchick et al., 2015), 
or uterus (Stapleton et al., 2015b). However, because TSP-1 and CD47 KO animals are 
only available in mice, we decided to adapt a technique for IVM in the mouse gluteus 
maximus muscle for our purposes. IVM of the arterioles of the mouse gluteus maximus 
has previously been established by the Segal group (Bearden et al., 2004, Bearden and 
Segal, 2004, Moore et al., 2010, Sinkler and Segal, 2014). Arteriolar reactivity in TSP-1 
and CD47 KO animals has been previously characterized in isolated vessels by the 
Isenberg group (Isenberg et al., 2006a, Isenberg et al., 2006b, Bauer et al., 2012, 
Csanyi et al., 2012), but reactivity using these KO strains of mice in an IVM setting has 
yet to be examined. In order to investigate the involvement of TSP-1 and CD47 in 
mediating changes in microvascular function following MWCNT exposure, it was first 
necessary to establish that we could satisfactorily perform IVM of the gluteus maximus 
microvasculature, and that we could demonstrate phenotypic differences between KO 
and WT animals. The following protocol and preliminary data represent our 
development of this technique at WVU.  
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Protocol for Intravital Microscopy 
 
1)  Anesthesia 
Anesthetization should be performed carefully, as mice are very sensitive to this 
barbiturate drug and it is extremely easy to overdose either to death or, much more 
easily, to depress the CV system enough that IVM measurements are impossible. With 
this in mind, going slowly with several small doses spread out over as much as 30 
minutes yields good results.  
a) Thiobutabarbital (Inactin, 100 mg/kg, i.p.) 
i) 10 mg  per ml of saline = .3 ml of solution 
b) Likely interval dosing over a 30 minute period 
c) 1 ml syringe and 27 gauge for introduction of anesthesia   
d) 0.05 ml increments, wait 10 minutes between doses 
 
2) 2: Tools/Equipment  
a) #7 forceps (extremely important for tracheostomy) 
b) Vannas scissors for cutting thin muscle layers. 
c) Polyethylene tubing (PE90) inch length, bevel edges  






a) Use heated stage to 37 degrees Celsius 
b) Shave anterior chest and neck 
c) Incision with skin scissors from below chin midline to upper extremities 
i) Deep to the skin there will be a thin transparent fascial layer that needs to be 
cut through 
ii) Blunt dissect down to trachea (should be able to see cartilaginous rings in 
microscope) 
(1) Abduct lobes of fat to expose muscle sheath around trachea 
(2) Blunt dissect muscle to expose trachea 
d) Suture wire 4-0 make a small loop and hold between needle driver/hemostat  
e) Use #7 forceps and go posterior to the trachea (between muscle layer and 
trachea) and grab the loop from the needle drivers 
i) Suture wire posterior to trachea (fig. 3.1) 
f) Make small incision between cartilage rings  
g) Use PE90 tube, insert  into trachea (about 1 cm) 
i) Make sure both lungs are inflating by observing equal chest rise 
h) Tie PE 90 tube with posterior placed suture wire 
i) Cut PE90 tube to chin length 





4) Gluteal Maximus Externalization 
a) Position the animal as indicated in figure 3.2 
b) Make an Incision slightly lateral to midline, working anteriorly first 
i) Running from hind limb, up towards midline ~2 cm, and then back lateral 
(see fig 3.3) 
c) Dissect small facial plane, avoid dissection into muscle (small amount of sub-Q 
tissue) 
d) Can also keep things moist with saline 
e) Make incision 1 mm medial to spine into tendon (white structure in picture) 
i) Vertical incision following medial incision plane 
f) Gluteus maximus striations runs laterally, with layering 1-2 mm in thickness 
(striations can be observed under microscope) 
g) Anchoring the gluteal muscles: 
i) Landmark (central vessel with branches off 
ii) 1-2 mm from edge of incision place suture 
(1) Centrally located (fig. 3.3) 
(2) Tie suture with small loop so it ties onto itself rather than the muscle 
(3) Secure muscle into stage and apply some traction in order to dissect 
farther down 
(a) Avoid large blood vessels while dissecting 
iii) Place 1 sutures superior to previous suture, again make a small loop during 
the tying process 
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(1) Place the superior aspect of the muscle into traction on the stand 
iv) Dissect any fat away from the superior surface of the gluteal muscle in order 
to create as much translucency as possible 
h) While dissecting the inferior medial aspect of the gluteal muscle avoid the 
neurovascular bundle  
i) Place suture #3 in the inferior medial aspect of the gluteal muscle (fig. 3.4) 
i) While the muscle is in traction, blunt dissect the fascia away (anatomically 
inferior to the gluteal muscle) 
i) Intermuscular fat between layers is often most highly vascular and best 
region to do IV microscopy 
(1) While dissecting will likely rupture some small vessels 
(2) 3 discrete vessel bundles to work with 
(a) Superior, medial (fig. 3.5), and inferior 
(b) Superior and medial are best to get images from, inferior tends to be 
too deep in the muscle tissue to adequately image 
j) Anatomically deep (now on the exposed surface) to the muscle is a fascial layer 
that need to be teased away (appears like cob webs under microscope) 
i) Will interfere with micro-pipet tip placement 
ii) Extremely gently scrape away layer, avoid tearing muscle and vessels  
k) Place stopcock grease along the edges to seal the bath 





5) Microiontophoresis and Micromanipulation  
a) Make and filter PSS solution ahead of time 
i) (119 mM NaCl, 25 mM NaHCO3, 6 mM KCl, and 3.6 mM CaCl2) 
ii) CaCl2 must be added at the time of experiment or will fall out of solution 
iii) Bubble with 5% CO2 90% N2 for 3 minutes prior to start of experiment 
(1) Continue bubbling throughout experiment 
b) Prepare glass micropipettes according to instructions using Dr. Nurkiewicz’s 
electronic pipette puller and grinder. 
i) Should have a ˜1 μm opening. 
ii) Make 1M ACh solution dissolved in double distilled water 
iii) Use micro capillary needle to backfill, ensure no air in tip (should be able to 
see a tiny bubble of solution form on the tip of the pipette) 
iv) Prepare at least 2 of these pipettes per animal, more if still learning.  
c) Secure micropipette in micromanipulator 
d) Insert platinum electrode wire in the blunt end 
e) Place lead wire from the current programmer into the PSS bath and turn on 
holding current (~200nA for 1M ACh) 
i) Fault alarm should sound, gently place pipette tip in the PSS, if alarm stops, a 




f) Raise objective until it is at the very surface of the PSS. The more room between 
the objective and muscle the better at this point. 
i) Using micromanipulator controls, carefully insert pipette tip into the bath and 
under the objective 
(a) ~ 45 degree angle 
ii) At this point, the pipette tip is probably both not directly under the objective 
and not in focus, so it has to be found 
(1) First step is to get the tip in the field of view of the objective. This is 
achieved by slowly sweeping the tip under the objective while looking 
through the eyepiece. A faint “shadow” should appear when the tip is in 
the field of view. This may take practice to be able to identify the shadow. 
(2) Once the tip is in the field of view, adjust focus until the tip is resolved. 
(3) Simultaneously lower tip and objective, keeping everything in focus, until 
the tip is at the surface of the muscle. 
g) Carefully place the micropipette tip adjacent to the target vessel 
i) Leave a few micrometers distance to prevent irritating the vessel when it 
dilates or spasms. 
ii) There may be invisible connective tissue making it difficult to place the tip 
exactly where it is wanted 
(1) Sometimes it is possible to work the tip through the tissue, other times it 
will need to be backed out and placed somewhere else 
h) At the end of the 20min equilibration period, start running curves 
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i) Raise the ejection current to achieve the desired total current and hold for 5 
minutes. 
(1) (Holding current – ejection current = total current) 
(2) i.e. 20, 40, 80, 120nA seems to work well for ACh and SNP 
(3) Apply in random order.  
(a) Some solutes (SNP) have opposite polarity and currents will need to be 
reversed. 
(4) Take 3 images at each time point over the course of a minute and 
average to account for any minor fluctuations in vessel diameter 
(a) If vessel is spasming, wait.  
(5) 5 minute washout period following each ejection period.  
(6) Following final washout period add 30mL syringe of PSS plus 10^-4M 
adenosine to line. (In place of large bottle).  
i) Analyze saved images to determine vessel diameter 
i) Use equations provided in chapters 4 and 5 










Figure 3.1 Mouse Tracheostomy. View of tracheostomy before 
placement of PE90 tubing. Note the placement of suture wire 










Figure 3.3. Externalization and fixation of the right gluteus maximus. The first suture is tied in at 




Figure 3.4. Fully externalized right gluteus maximus. Three suture wires secure the muscle flap in a PSS 










Arteriolar responses to acetylcholine, and phenylephrine were assessed in 
skeletal muscle arterioles of global TSP-1 knockout (KO) and wildtype (WT) littermate 
mice using IVM of the gluteus maximus.  KO animals demonstrated 10.7%, 18.6%, 
16.5% greater vasodilatory response to acetylcholine concentrations of 10-6, 10-4, and 
10-2M (p < 0.05) (Fig 3.6). WT vessels demonstrated 23.8% greater constriction than 
KO at the highest concentration of phenylephrine, 10-3M (p < 0.05) (Fig. 3.7).  
The results of this preliminary work established that our TSP-1 KO animals 
indeed exhibited phenotypically different arteriolar reactivities from WT controls, and 
that we were capable of reliably manipulating this system, thus establishing the 
































Figure 3.6. Endothelium dependent vasodilation. Arteriolar % change from baseline following 
administration of acetylcholine (ACh) from wildtype (WT, n = 13) and thrombospondin-1 KO 
(KO, n = 13) groups.  (*) indicates difference between genotype. Values are mean ± SE. n 
































Figure 3.7.  α-adrenergic sensitivity. Arteriolar % change from baseline following administration of 
phenylephrine (PE) from wildtype (WT, n = 6) and thrombospondin-1 KO (KO, n = 8.) groups.  (*) 
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 Pulmonary exposure to multi-walled carbon nanotubes (MWCNT) has been shown 
to disrupt endothelium-dependent arteriolar dilation in the peripheral microcirculation. 
The molecular mechanisms behind these arteriolar disruptions have yet to be fully 
elucidated. The secreted matricellular matrix protein thrombospondin-1 (TSP-1) is 
capable of moderating arteriolar vasodilation by inhibiting soluble guanylate cyclase 
activity. We hypothesized that TSP-1 may be a link between nanomaterial exposure and 
observed peripheral microvascular dysfunction. To test this hypothesis, wild-type C57B6J 
(WT) and TSP-1 knockout (KO) mice were exposed via lung aspiration to 50 µg MWCNT 
or a sham dispersion medium control. Following exposure (24hrs), arteriolar 
characteristics and reactivity were measured in the gluteus maximus muscle using 
intravital microscopy (IVM) coupled with microiontophoretic delivery of acetylcholine 
(ACh) or sodium nitroprusside (SNP).  In WT mice exposed to MWCNT, skeletal muscle 
TSP-1 protein increased > 5-fold compared to sham exposed, and exhibited a 39% and 
47% decrease in endothelium-dependent and independent vasodilation, respectively.  In 
contrast, TSP-1 protein was not increased following MWCNT exposure in KO mice and 
exhibited no loss in dilatory capacity. Microvascular leukocyte leukocyte-endothelium 
interactions were measured by leukocyte adhesion and rolling activity in assessing third 
order venules. The WT+MWCNT group demonstrated 223% higher leukocyte rolling 
compared to WT+SHAM controls. TSP-1 KO animals exposed to MWCNT showed no 
differences from WT+SHAM control.  These data provide evidence that TSP-1 is likely a 
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central mediator of the systemic microvascular dysfunction that follows pulmonary 
MWCNT exposure.  
 
Keywords 





Anthropogenic materials designed and manufactured to take advantage of unique 
properties displayed at the nanoscale (less than 100 nm in one dimension) are known as 
engineered nanomaterials (ENM) (Borm and Mueller-Schulte, 2006). With applications 
ranging from aerospace to biomedicine, ENM are rapidly becoming an integral part of our 
global economy.  It is becoming increasingly apparent that ENM exposure, especially via 
the lungs, can result in significant toxicities in both the pulmonary and cardiovascular 
systems. Because of their growing ubiquitous commercial and industrial use and wide 
ranges of ENM characteristics (e.g. size, shape, redox status, surface functionalization, 
and rate of dissolution), there is critical need to better understand the biological 
responses of ENM in mammals.  At present, however, the molecular signaling events 
underpinning cardiovascular ENM toxicity are not completely understood.   
Of particular concern are ENM-mediated changes in microvascular function, 
specifically the ability of the arterioles to maintain appropriate resistance and reactivity 
through paracrine signaling from the vascular endothelium. The arterioles, in contrast to 
larger conduit and compliance vessels, are particularly important in blood flow regulation 
as they are the principal source of active peripheral resistance in the systemic vasculature. 
There is increasing evidence that exposure to ENM, especially via pulmonary routes, can 
result in disruption of normal arteriolar function. In vitro studies have demonstrated 
changes in autophagic cell death (Yamawaki and Iwai, 2006, Stern et al., 2012, Zhang et 
al., 2016a) in human vascular endothelial cells following nanomaterial exposure. A 
significant pro-inflammatory shift (Gojova et al., 2007, Corbalan et al., 2011, Zhu et al., 
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2011) in endothelial cells has also been noted, and may be the result of generation of 
reactive oxygen species (Liu and Sun, 2010). Reduced capacity for arteriolar (Stapleton 
et al., 2012a) endothelium-dependent vascular relaxation, as well as enhanced coronary 
arterial vasoconstriction (Thompson et al., 2014) following pulmonary exposure to multi-
walled carbon nanotubes (MWCNT) has been documented. While oxidative stress has 
been observed in these studies, the underlying molecular mechanisms for many of these 
changes remain to be fully defined.  
  Arteriolar diameter is the result of a complex interplay between neural, 
endocrine, paracrine, and local metabolic factors. By responding to these inputs via 
changes in contractile activation of myosin and actin in the vascular smooth muscle cells, 
the arterioles contribute to the maintenance of homeostasis by altering resistance to 
match blood flow to local metabolic demand while simultaneously adapting to systemic 
pressure gradient changes. In this manner, adequate tissue perfusion is maintained and 
capillary damage due to excess pressure and flow is prevented.  One of the most 
important factors in this regulatory system is the ability of the vascular endothelium to 
stimulate smooth muscle relaxation via nitric oxide (NO). The vascular endothelium is 
responsible for detecting changes in physical influences such as shear stress, as well as 
humoral influences including the neurotransmitters acetylcholine (ACh) and 
norepinephrine. These signals are transduced through activation of endothelial nitric 
oxide synthase (eNOS) via both calcium dependent and calcium independent pathways 
(Fleming et al., 1997). First discovered in the context of its role in wound healing, TSP-1 
comprises the bulk of the protein found in the alpha granules of platelets (Baenzige.Nl et 
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al., 1971). Part of a larger six member thrombospondin family, TSP-1 is a 450 kD homo-
trimeric glycoprotein shown to be an important regulator of multiple points in the NO 
signaling pathways. This control is achieved primarily through binding to cell surface 
receptor CD47 in the vascular smooth muscle, and limiting cGMP production (Isenberg et 
al., 2005a) by inhibiting sGC activity (Isenberg et al., 2006b).  TSP-1/CD47 can also inhibit 
eNOS activity by altering Ca2+ transients in endothelial cells, blocking phosphorylation of 
eNOS at serine1177 (Bauer et al., 2010). Another receptor for TSP-1 more commonly 
associated with regulation of angiogenesis, CD36, may also play a role in inhibiting eNOS 
by displacing it from intracellular caveolae (Shaul, 2003). The TSP-1/CD47/CD36 signaling 
axis has been implicated as a contributing factor, or in the etiology, to a number of 
disease states, including coronary artery disease (Celermajer et al., 1992, Schachinger et 
al., 2000), obesity and metabolic syndrome (Steinberg et al., 1996, Varma et al., 2008, 
Matsuo et al., 2015), hypertension (Panza et al., 1990, Boulanger, 1999), peripheral 
arterial disease (Smadja et al., 2011), diabetes mellitus (Cai and Harrison, 2000), stroke 
(Cho, 2012) among others (Roberts et al., 2012, Kong et al., 2013). 
Despite the apparent involvement of TSP-1 in influencing endothelial function and 
arteriolar reactivity, the effect of ENM exposure on its expression and activity and 
subsequent cardiovascular effects have yet to be investigated. In the current study, we 
hypothesize that pulmonary MWCNT exposure elevates peripheral expression of TSP-1 
protein, mediating systemic arteriolar endothelial dysfunction; and that mice lacking the 
TSP-1 gene (i.e. knockout mice) will be protected from this effect due to the lack of TSP-





C57BL/6J background TSP-1 knockout (TSP-1 KO) and C57BL/6J animals (WT) 
were purchased from Jackson Labs, Bar Harbor, ME (Stock# 006141 and 000644, 
respectively) and used to develop an in house breeding colony. Mice were housed 
according to NIH Use of Laboratory Animals, Animal Welfare Act, and all experiments 
were approved by the West Virginia University Institutional Animal Care and Use 
Committee. Mice were kept on a 12 hour light/dark cycle, and provided food and tap 
water ad libitum.  Experiments were scheduled so that data collection occurred at 
approximately 16 weeks of age. At this age, the mice are sexually and developmentally 
mature and the gluteus maximus muscle is of sufficient size and strength to undergo 
intravital microscopy (Flurkey et al., 2007). In order to reduce the number of waste 
animals generated, both male and female WT and KO animals were used in all 
experiments in approximately equal numbers (Table 1). We have observed no significant 
sex differences in vessel baseline diameter, maximal passive diameter, or reactivity before 
and after nanomaterial exposure.  
[Table 1 near here] 
 
Nanomaterial exposure details 
MWCNT are catalytically grown by chemical vapor deposition processes and were 
obtained from Mitsui & Co (MWNT-7, Lot # 061220-31, Ibaraki, Japan). Mitsui-7 MWCNTs 
were designated as the ENM of choice for this project based on the wide number of 
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potential applications, observed toxicity, and prior investigations by our group (See below 
for physico-chemical details) Oropharyngeal aspiration, as opposed to intratracheal 
instillation or aerosol inhalation was chosen as the method of exposure for this study due 
to the high degree of flexibility and scalability compared to inhalation, and is less 
traumatic for the animals than intratracheal instillation (Rao et al., 2003). Aspiration of 
this dose of MWCNT in dispersion medium generates pulmonary response analogous to 
instillation (Bonner et al., 2013) and inhalation (Shvedova et al., 2008, Mercer et al., 
2011). Similar patterns of altered systemic vascular reactivity and NO signaling were 
observed in this study when compared to similar measurements following inhalation of 
aerosolized MWCNT (Nurkiewicz et al., 2009). While anesthetized with isoflurane, solution 
of 50 μg MWCNT suspended and dispersed using ultrasonication in a phospho-buffered 
saline/purified mouse serum albumin (PBS/MSA) medium was placed in oropharynx with 
the tongue manually extended. Upon release, the tongue retracts and the mouse 
reflexively inhales, aspirating the material and depositing in the lung(Rao et al., 2003). 
This dose of MWCNT has been shown to cause lung injury and inflammation using the 
same exposure method as used in this study (Porter et al., 2010). Control animals 
received a sham aspiration of medium without nanomaterials. This dispersion medium 
(DM) has been shown to be both biocompatible, no immunogenic, and effective at 





Nanomaterial Physico-chemical properties 
Extensive characterization of the MWCNT has been previously reported (Porter et 
al., 2010). In summary, the overall MWCNT trace metal contamination was determined 
to be 0.78%, with sodium and iron being the major metal contaminants and is free of 
endotoxin. Because of the presence of iron, reactive oxygen species generation from 
MWCNT was investigated using electron spin resonance (ESR) spectroscopy. No hydroxyl 
radical generation was detected from MWCNT in acellular ESR experiments, indicating 
the iron present in MWCNT was not capable of generation reactive oxygen species. X-ray 
photoelectron spectroscopy measurements indicated the formation of the hydroxyl 
groups on the nanotube surface, which was consistent with the -11 mV zeta potential of 
the MWCNT in DM. High resolution transmission electron microscopy determined the 
number of walls ranged from 20 to 50. MWCNT width distribution followed a normal 
distribution with count mean width of 49 ± 13.4 (S.D.) nm, while MWCNT length 
distribution was log normal with median length of 3.86 µm (GSD 1.94). 
 
Intravital microscopy and iontophoresis of mouse gluteus maximus arterioles 
[Figure 1 near here.] 
At 24-h post-aspiration, KO or WT mice were anesthetized using thiobutabarbital 
(Inactin, 100 mg/kg, i.p.) and placed on a thermo-probe regulated heating pad to 
maintain a 37 °C core temperature. The trachea was intubated to ensure a patent airway. 
The right gluteus maximus muscle was surgically exteriorized for microscopic observation, 
leaving its innervation and all feed vessels intact. This site of observation was chosen as 
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skeletal muscle is the largest global reservoir of the microvasculature and the largest 
source of active peripheral resistance. After exteriorization, the muscle was secured over 
an optical pedestal with 5-0 suture wire at its in situ length. The pedestal was sealed with 
grease to create a superfusate bath. Throughout the surgery and following experimental 
period, the muscle was continuously superfused with an electrolyte solution (119 mM 
NaCl, 25 mM NaHCO3, 6 mM KCl, and 3.6 mM CaCl2), warmed to 35 °C, and equilibrated 
with 95% N2–5% CO2 (pH = 7.35–7.40). Superfusate flow rate was maintained at 4 
ml/min to minimize equilibration with atmospheric oxygen. 
The animals were transferred to an intravital microscope coupled to a digital video 
camera. Observations were made with a 20X water immersion objective. A micropipette 
with an opening of 1-2 µm was filled with a 10-2 M acetylcholine (to measure endothelium 
dependent vasodilation) or sodium nitroprusside (to measure endothelium independent 
vasodilation) solutions. The tip of the pipette was guided under microscope to a point 
adjacent to the adventitia of the target arteriole. During this time a holding current of -
200 nA or 200 nA, respectively, was applied to the bath to prevent ACh/SNP leakage from 
the pipette. Once in place and following a 20-minute equilibration period, ejection 
currents of 20 nA, 40 nA and 80 nA, and 120 nA (for ACh) or -20 nA, -40 nA and -80 nA, 
and -120 nA (for SNP) were applied to the bath for 5 minutes each in a randomized order, 
with a 5-minute washout period between each step. Following the final ACh/SNP washout 
period, adenosine was added to the superfusate at a concentration of 10-2 M to determine 
vessel maximal passive diameter. Images were displayed on a high-resolution computer 
monitor and digitally captured in the last minute of each step for later analysis using 
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ImageJ (ImageJ 1.46v, National Institutes of Health). One to three first order arterioles 
were studied per mouse. Measurements of vessel diameter were made from recorded 
images. Vessel reactivity is reported as percent of maximal diameter achieved. Resting 
vascular tone was calculated for each vessel as follows:𝑡𝑜𝑛𝑒 =  [
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑐
𝐷𝑝𝑎𝑠𝑠
] 𝑥 100, where 
D is arteriolar diameter, in micrometers, and Dpass is passive diameter under ADO, and Dc 
is the diameter measured during the control period. Dc was taken following a 20-minute 
equilibration and only if no change in vessel diameter had been observed for at least 1 
minute prior. Percent relaxation was calculated at each ACh or SNP ejection current as 
follows: % 𝑟𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 =  [
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑖𝑜𝑛
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑐
]  𝑥 100, where Dion is the vessel diameter following 
5 minutes of drug delivery via iontophoresis. 
 
Leukocyte adhesion and rolling 
     Prior to the start of iontophoresis, venules three branch orders from the capillaries, 
approximately 50 µm in diameter, and within 100 µm of target arterioles (typically the 
paired venule) were identified and video recordings made. Adhering or rolling leukocytes 
were quantified to characterize microvascular inflammation. Leukocytes that were either 
stationary or moving but in constant contact with the venular wall for at least 200 µm 
were counted for 1 min in each venule studied. Following the completion of iontophoresis 
studies and after a 20 minute washout period, 10-4 M apocynin was added to the 
superfusate to examine contributions of NADPH oxidase generated reactive oxygen 





TSP-1 tissue protein 
Following the IVM procedure, animals were sacrificed and triceps surae muscles 
(gastrocnemius, soleus, and plantaris) were harvested and immediately snap frozen in 
liquid nitrogen. Homogenates were centrifuged at 4 °C, at 8,000 g for 10 minutes, and 
supernatants removed and placed in new tubes. Total protein was measured by Bradford 
assay (#23236 Pierce Coomassie Plus Protein Assay Kit, Thermo Scientific, Rockford, IL, 
USA). Muscle samples were denatured (36 μg GA) and separated on 26-well 8% Bis-Tris 
Midi SDS-PAGE Gels (Novex WG1003BX10, Carlsbad, CA, USA) for 45 min at 120 V and 
blotted onto a 0.45 μm nitrocellulose membrane (nitrocellulose membrane no. 88018, 
Thermo Scientific, Rockford, IL, USA) for 90 min at 50 V. Total lane protein was 
determined using Ponceau S stain (0.1 % (w/v) in 5% acetic acid, P7170 Sigma-Alrdrich, 
St. Louis, MO). The membrane was blocked with 5% fat free milk in Tris buffered saline 
and probed with antibodies: TSP-1 (1:500, A6.1, sc-59887, Santa Cruz Biotechnology, 
Santa Cruz, CA, USA). Chemiluminescence detection allowed for visualization of proteins 
(Pierce ECL Western Blotting Substrate, no. 32209, Rockford, IL, USA), images of blots 
were taken using Genesnap software (version 7.01; Syngene, Frederick, MD, USA) after 
25 min exposure. Densitometry was measured using Image Studio Lite Version 5.2 (Li-
Cor Biosciences, Lincoln, NE, USA). Values are reported as target protein densitometry 






Statistics and calculations 
A D'Agostino & Pearson omnibus normality test was used to assess homogeneity 
of variance. In cases where non-normal datasets were detected, statistical comparisons 
were made with Kruskal-Wallis tests and post-hoc Wilcoxon rank-sum tests for between 
subject effects where appropriate.  A 2 x 2 factorial ANOVA was performed to compare 
the main effects of exposure (sham vs MWCNT) and genotype (WT vs KO) for each 
variable.  When significant main effects were observed a Sidak post-hoc test was used to 
determine where significant differences existed between the groups. In all cases, p < 
0.05 was used to establish statistical significance.  All data are reported as mean  SEM, 
unless otherwise noted.  
 
Results 
TSP-1 Skeletal Muscle Protein 
[Figure 2 near here] TSP-1 protein was assessed in skeletal muscle 24 hrs. post-
aspiration. TSP-1 protein increased by 512±21% in the WT+MWCNT group compared to 
sham controls (Fig. 2). TSP-1 protein in both TSP-1 KO groups was significantly lower 
than control and did not change with treatment. The interaction of Exposure and 
Genotype was significant (F (1, 19) = 8.5, p = 0.009). 
Baseline and maximal passive diameter 
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There were no differences between any groups or genders in baseline vessel 
diameter, maximal passive diameter, or spontaneous vessel tone (Table 2). [Table 2 near 
here] 
Endothelium-dependent vasodilation 
Significant differences in absolute arteriole diameter were noted between groups 
with both ACh and SNP stimulation. (Fig. 3). [Figure 3 near here]. However, to normalize 
for variation in baseline diameter, % relaxation will be used henceforth as a measure of 
arteriolar reactivity (Fig. 3). Full vessel diameter curves for each group are presented in 
supplemental figures 1 and 2.  At 120 nA ACh ejection current, TSP-1 KO+SHAM animals 
demonstrated enhanced vasodilatory capacity compared to WT+SHAM (125±19% vs 
90±3%). Enhanced dilatory capacity was maintained in the TSP-1 KO + MWCNT exposure 
(121±8%). In contrast, WT+MWCNT animals exhibited a significantly blunted response 
to ACh compared to control and TSP-1 KO (61±9%). A similar response was noted at 80 
nA ejection current; the KO+SHAM group was able to dilate to a greater extent than 
WT+SHAM (97±6% vs 56±9%). Dilatory capacity was again maintained in the 
KO+MWCNT group (110±7%) while the WT+MWCNT group was limited to 39±14%. At 
40 nA, both KO+SHAM and KO+MWCNT groups were able to dilate more than 
WT+MWCNT (45±16%, 54 ±9%, respectively vs 15±11%). The KO+MWCNT was able 
to dilate greater than WT+SHAM control 45±17%). No significant differences were 
observed at the 20 nA acetylcholine ejection current level. There was no observed 
interaction between Ejection Current and Genotype (F (15, 141) = 1.585, P = 0.0850) 
Area under the curve for each group is as follows in units of % dilation x ejection current; 
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WT+SHAM, 5777±215, WT+MWCNT, 3224±452.5*, KO+SHAM*†, 7698±213, 
KO+MWCNT 8584±483*†. (*) indicates difference from WT+SHAM, (†) indicates 
difference from WT+MWCNT. 
Endothelium-independent vasodilation 
[Figure 4 near here] 
When stimulated with the membrane dependent NO donor SNP, the WT Sham 
group and both TSP-1 KO groups were able to achieve similar levels of vasodilation at 
120 nA ejection current (WT+SHAM 108±7%, KO+SHAM 107±5%, KO+MWCNT 
101±6%) (Fig. 4). The WT+ MWCNT group demonstrated a significantly reduced 
vasodilatory response compared to the other groups, (61±7%). At the 80nA ejection 
current the KO+SHAM group demonstrated enhanced dilation compared to WT+MWCNT 
(108±7% vs. 66±7%). There was no observed interaction between Ejection Current and 
Genotype (F (5, 45) = 1.230, P = 0.3110)  Area under the curve for each group is as 
follows in units of % dilation x ejection current; WT+SHAM, 10478+ WT+MWCNT, 
5938±698*, KO+SHAM, 10124±886.9*†, KO+MWCNT 9254±1641*†. (*) indicates 
difference from WT+SHAM, (†) indicates difference from WT+MWCNT. 
 
Leukocyte adhesion and rolling 
[Figure 5 near here] 
A component of vascular inflammation, leukocyte adhesion was assessed by 
measuring leukocyte flux (CPM) through third order venules during intravital experiments 
(Fig. 5) For the WT+SHAM group, the mean flux was 79.3±6.9 CPM. The WT+MWCNT 
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group demonstrated an 81% increase in leukocyte flux compared to sham control 
(176.7±13.5 CPM). The KO+MWCNT did not demonstrate significantly increased 
leukocyte flux compared to the WT+SHAM group, but was lower than WT+MWCNT 
(100.3±9.1 CPM). Following 30 minutes of incubation with 10-4 M apocynin in the 
physiologic saline solution (PSS) superfusate, repeat measurements were made on the 
same vessels. All groups demonstrated significant reductions in leukocyte flux, compared 
to PSS alone (WT+SHAM; 44.7±5.9 CPM, WT+MWCNT; 86.4±8.2 CPM, KO+MWCNT; 
55.5±5.2 CPM). Both WT+SHAM and KO+MWCNT were lower than WT+MWCNT group 
following apocynin incubation. Apocynin decreased leukocyte flux in the WT+MWCNT 
group to a level similar to the WT+SHAM group with PSS alone.  
 
Discussion 
The key finding of the current study is the apparent involvement of TSP-1 in 
mediating pulmonary MWCNT exposure induced disruption in peripheral vascular 
function, as demonstrated by the protection offered to the TSP-1 KO group following 
MWCNT exposure.TSP-1 KO animals were able to achieve similar dilation after MWCNT 
exposure in response to both ACh and SNP stimulation compared to sham controls. These 
data represent the first evidence that TSP-1 may act as a key mediator in the 
microvascular dysfunction that follows MWCNT exposure. Intravital microscopy and 
iontophoresis in the mouse gluteus maximus microvasculature has been well established 
(Bearden and Segal, 2004, Jackson and Segal, 2006, Sinkler and Segal, 2014), and 
compared to preparations using isolated vessels, mesentery artery, hamster cheek pouch, 
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or cremaster, the gluteus maximus preparation allows visualization of fully perfused and 
innervated microvasculature in locomotive skeletal muscle.  The results of this MWCNT 
exposure were obtained by using a powerful technique for the assessment of 
microvascular function in vivo combined with a well-characterized KO model. This study 
also represents one of a handful of attempts to use KO animals to investigate molecular 
mechanisms of nanotoxicity (Bagher et al., 2011b, Louro et al., 2014, Chen et al., 2015, 
Aragon et al., 2016), and is the first in the area of the peripheral microcirculation.  
Our findings of impaired vasodilation agree with previously undertaken 
investigations of arteriolar reactivity following MWCNT as well as other ENM exposures. 
As a large endocrine, paracrine, and autocrine organ, the vascular endothelium is a 
smooth monolayer of cells lining interior vessel lumen and has a number of responsibilities 
aside from regulating vessel diameter, including balancing pro- and anti-inflammatory 
factors, regulating vascular permeability, and moderating leukocyte adhesion and rolling 
(Inagami et al., 1995). Stapleton et al. demonstrated significant inhibition of endothelium 
dependent dilation in response to increasing concentrations of ACh (10-9 M – 10-4 M) 24 
hrs. post MWCNT inhalation in isolated rat coronary arterioles. This inhibition was 
maintained out as far as 168 hours post-exposure. Impaired responsiveness to the 
calcium ionophore A23187 was also observed at 24 hours, and persisted to a lesser 
degree at longer time points (Stapleton et al., 2012a). In a separate study, this group 
has also presented evidence that lung nanomaterial exposure generates peripheral 
microvascular ROS stress and decreased NO bioavailability (Nurkiewicz et al., 2009). The 
authors reported that endothelium dependent vasodilation (via A23187 incubation) was 
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inhibited, however vascular smooth muscle sensitivity to exogenous NO donation was not 
impaired. When vessels were incubated TEMPOL/catalase, apocynin, or ABAH, normal 
endothelial function was partially restored.  In contrast, in our study when stimulated 
with SNP, all groups except for the WT+ MWCNT were able to achieve similar levels of 
dilation, indicating deficits in smooth muscle NO responsiveness. The discrepancy here 
might be explained by several differences between the studies, such as different species 
and microvascular bed. Keeping in mind our observed concomitant increase in TSP-1 
protein levels, it follows that the WT+MWCNT would still exhibit blunted endothelium-
independent vasodilation, as TSP-1 primarily acts to limit vasodilation by inhibiting the 
NO-sGC-cGMP pathway downstream of sGC at the cGMP-dependent kinase (Miller et al., 
2010). We also observed that TSP-1 KO animals were able to achieve robust vasodilation 
in response to increasing doses of ACh. The role of the TSP-1/CD47 axis in mediating 
smooth muscle contractile activity has been extensively characterized (Isenberg et al., 
2005b, Isenberg et al., 2006a, Isenberg et al., 2007a). Most relevant to the current study 
was work published in 2010 by Bauer et al. (Bauer et al., 2010). In this study, the authors 
report similar levels of relaxation (~125% of maximal passive diameter) in response to 
ACh in TSP-1 null animal vessels. Furthermore, when exogenous TSP-1 was supplied, 
“normal” relaxation was restored. The authors observed a similar disruption in dilatory 
capacity in CD47 KO animals, however when exogenous TSP-1 was supplied, the impaired 
dilation remained, suggesting that CD47 receptor is an important pathway involved with 
these TSP-1 mediated effects. But it is likely that TSP-1 signaling following nanomaterial 
exposure is not limited to CD47.  
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Recently, a role for CD36 has been described in mediating vascular dysfunction 
following MWCNT inhalation (Aragon et al., 2016). The authors report that endothelial 
cells incubated in serum collected from mice post exposure generated significantly less 
NO, independent of NO scavenging. Furthermore, isolated aortic rings incubated in 
exposed serum exhibited decreased vasodilatory responses to acetylcholine.  When the 
same procedure was repeated on aortic rings isolated from CD36 KO animals, the 
impairment was abolished, suggesting that factors released in lungs exposed to MWCNT 
are able to exert peripheral effects. In this case, the authors report elevated matrix 
metallopeptidase-9 (MMP-9) as one potential culprit, as serum from MMP-9 KO mice 
induced a modest right-shift effect on the concentration response to ACh, but did not 
completely reduce the overall magnitude of relaxation. 
While there is strong evidence for disruption of endothelium dependent 
vasodilation by direct action of TSP-1 on the NO signaling pathway, it is also possible that 
TSP-1 may also interfere with NO signaling through endothelium independent 
mechanisms. For example, activated leukocytes released from the lung adhering to and 
rolling on the venular walls is known to increase ROS activity (Stapleton et al., 2007). Our 
observation that leukocyte adhesion and rolling was enhanced in WT mice after 
pulmonary MWCNT exposure is in agreement with previous work with pulmonary 
exposure to other particulate matter (Nurkiewicz et al., 2004, Stapleton et al., 2015b). 
Our data represent the first demonstration that the loss of TSP-1 afforded protection to 
the microvasculature, as evidenced by reduced leukocyte rolling in TSP-1 KO compared 
to WT MWCNT exposed mice. At present, the molecular signaling responsible for the 
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observed increase in skeletal muscle TSP-1 protein remains unclear, however we 
speculate that the pathway likely involves lung injury and innate immune response, 
leading to the activation of leukocytes. Evidence supporting this is robust as MWCNT are 
capable of being injurious and pro-inflammatory to the pulmonary epithelium (Porter et 
al., 2010, Porter et al., 2013) including increasing permeability (Thompson et al., 2016) 
and enhancing levels of plasma inflammatory cytokines (Crouzier et al., 2010). Indeed, 
TSP-1 is strongly expressed in leukocytes (Wight et al., 1985) and platelets (Brown and 
Frazier, 2001) which are activated the lung (Morimoto et al., 2013) and in the blood 
(Bihari et al., 2010) and form circulating conjugates following nanotube exposure-related 
lung injury (Nemmar et al., 2007). TSP-1 activation of its CD47 receptors is also well 
known as positive regulators of leukocyte-endothelium adhesion (Brown and Frazier, 
2001, Narizhneva et al., 2005), stimulating expression of cell adhesion molecules ICAM-
1 and VCAM-1 (Narizhneva et al., 2005). Therefore, it is possible that TSP-1 may act to 
encourage leukocyte adhesion to the vessel wall, promoting NO quenching while 
simultaneously disrupting NO signaling through CD47 signaling.  
The present study was focused on the acute time-frame to determine if TSP-1 was 
an important factor involved in peripheral vascular dysfunction following exposure to 
MWCNT. Future work investigating the role of TSP-1 at time points past 24hrs are 
necessary. The long-term consequences of pulmonary exposure to MWCNT are unclear, 
but there is increasing evidence support a link between MWCNT exposure and 
development of atherosclerosis.  Apolipoprotein E −/− mice fed a western (high fat) diet 
in conjunction with chronic exposure to MWCNT have been observed exhibiting modest 
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pulmonary inflammation (Han, 2016), oxidative damage to lung DNA, aortic remodeling 
(Christophersen et al., 2016), accelerated plaque progression (Cao et al., 2014), and 
enhanced expression of adhesion molecules (Suzuki et al., 2016). Human microvascular 
endothelial cells exposed to MWCNT either directly(Cao et al., 2014, Suzuki et al., 2016) 
or indirectly through co-culture(Snyder-Talkington et al., 2013) with lung epithelial cells 
respond with increased expression of adhesion molecules and oxidative stress. TSP-1 is 
a regulator of the cell adhesion molecules ICAM-1 and VCAM-1 (Narizhneva et al., 2005). 
These CAMs are involved in several important steps of atheroma formation (Obrien et al., 
1993, Nakai et al., 1995, Nakashima et al., 1998, Choi et al., 2012) and elevated 
circulating TSP-1 is associated with development of atherosclerosis. (Choi et al., 2012). 
With these results in mind, it seems likely that TSP-1 may play a role in MWCNT-induced 
atherosclerosis which requires further investigation. 
 
Conclusions 
We have demonstrated for the first time that TSP-1 is a link between pulmonary 
nanomaterial exposure and peripheral changes in arteriolar function. In our study, lung 
MWCNT exposure in WT mice yielded increases in peripheral TSP-1 protein, enhanced 
leukocyte adhesion and rolling activity, and decreased arteriolar vasodilatory 
capacity.TSP-1 KO animals were largely protected from loss of vasodilatory response 
observed in arterioles of WT mice. This protection afforded to TSP-1 KO animals may be 
due to a combination of reduced leukocyte adhesion, enhanced NO signaling, reduced 
ROS stress, or some combination of all these mechanisms. Taken together, these data 
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indicate a significant role for TSP-1 in mediating impaired peripheral microvascular 
reactivity following MWCNT exposure. More investigation is required to determine 
precisely what factors in the TSP-1 signaling pathway are involved, but likely it is the 
receptors CD47 and CD36. It will also be valuable to evaluate the role of TSP-1 over a 
period of days or weeks following MWCNT and other ENM exposure, especially in the 
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Table 4.1. Animal Characteristics. No significant differences were observed between 






  Animal Characteristics  















Age (weeks) 16.5±0.6 16.4±0.5 16.6±0.4 15.8±0.5 





Table 4.2. Baseline vessel characteristics. No significant differences were observed 
between groups of vessels used for microiontophoresis experiments in baseline or passive 






 Vessel Characteristics 





n (vessels) 21 15 17 16 
Baseline Diameter (µM) 34.4±2.4 34.9±2.0 33.4±2.2 34.4±3.3 
Passive Diameter (µM) 52.0±2.6 49.65±2.6 51.2±3.5 57.5±3.3 




























Figure 4.1 Graphical depiction of intravital microscopy experiments. Following an 
equilibration period, baseline vessel diameter is measured. Then, acetylcholine or sodium 
nitroprusside are applied via iontophoresis at varying currents to measure vessel 
reactivity. Finally adenosine is applied to measure passive diameter. Vessel reactivity is 
reported as a percentage of the passive diameter achieved with adenosine stimulation.  
 
Figure 4.2 Skeletal muscle thrombospondin-1 protein level following lung multi-walled 
carbon nanotube exposure.  TSP-1 protein increased by 512±21% in the WT+MWCNT 
compared to WT+SHAM group. TSP-1 KO protein levels were at the limit of detection. 
Values are mean ± SE. Lanes depict individual animals. n represents number of animals 
studied, (*) indicates difference from WT+SHAM. (†) denotes difference from 
KO+MWCNT. 
 
Figure 4.3 Arteriolar diameter following multi-walled carbon nanotube (MWCNT) 
aspiration.  Representative vessel diameter following administration of acetylcholine (Ach) 
from wildtype (WT, n = 7) and thrombospondin-1 (TSP-1, n = 12) KO groups 24 hrs. 
following exposure to MWCNT. Vessel diameter curves for every group and drug condition 
are provided in supplemental figures 1 and 2. (*) indicates difference from baseline. (†) 
indicates difference from previous ejection current value. (a) indicates difference between 
groups. Values are mean ± SE. n represents number of vessels studied 
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Figure 4.4 Endothelium dependent and independent arteriole dilation following MWCNT 
aspiration. Acetylcholine (A) dose response curves in WT + SHAM (n = 7), WT + MWCNT 
(n = 7), TSP-1  KO + SHAM (8), and TSP-1  KO + MWCNT ( n = 12) and SNP  dose 
response curves (B) WT + SHAM (n = 7), WT + MWCNT (n = 7), TSP-1  KO + SHAM (5), 
and TSP-1  KO + MWCNT ( n = 8) 24 hours post exposure. (*) indicates difference from 
WT+SHAM. Values are mean ± SE. n represents number of vessels studied. 
 
Figure 4.5 Skeletal muscle venule leukocyte adhesion and rolling following lung multi-
walled carbon nanotube aspiration. Leukocyte adhesion and rolling was enhanced in the 
WT+MWCNT group (n = 13 vessels) compared to WT+SHAM control group (n = 13), but 
not the KO+MWCNT group (n = 14). Incubation with 10-4 M apocynin reduced leukocyte 
flux in the WT+MWCNT to levels comparable to sham controls. (*) indicates difference 
from WT+SHAM. (†) denotes difference from WT+MWCNT. (‡) indicates difference from 
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 Pulmonary exposure to multi walled carbon nanotubes (MWCNT) and other 
nanomaterials have been shown to disrupt peripheral microvascular function. We recently 
demonstrated that levels of thrombospondin-1 (TSP-1) were increased in skeletal muscle 
following MWCNT exposure. TSP-1 is a matricellular glycoprotein highly expressed 
activated platelets during lung injury and inflammation. TSP-1 KO animals exhibited no 
impairments in skeletal muscle microvascular function following MWCNT exposure 
compared to WT controls. The mechanism through which TSP-1 exerts influence on 
vascular function in this state has yet to be determined, but we hypothesized that CD47 
(a TSP-1 receptor) may be important for mediating changes in NO production, 
bioavailability, and signaling.  
To test this, wildtype (WT) or CD47 knockout (CD47-KO) C57B6/J-background 
animals were exposed to 50 µg of MWCNT or sham control via pharyngeal aspiration. 24 
hrs. post-exposure intravital microscopy of the right gluteus maximus muscle was 
performed to assess arteriolar function via microiontophoretic delivery of varying doses 
(20, 40, 80, 120 nA0 of acetylcholine (ACh). Nearby venules were also imaged and 
recorded for 60 seconds to measure the number of adherent or rolling leukocytes. 
Immediately following the intravital procedure, lung, plasma, and left gluteus maximus 
tissues were collected for later analysis. Electron paramagnetic resonance (EPR) and NOx 
measurements were performed to assess tissue redox status, while inflammatory 
biomarkers were measured via multiplex assay.  
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Endothelium-dependent vasodilation as stimulated by ACh was significantly impaired in 
the WT + MWCNT group compared to control (56.9 ± 8.9% vs 89.6 ± 2.3% relaxation), 
while CD47 KO animals showed no impairment (108.46 ± 7.8% relaxation). Venular 
leukocyte adhesion and rolling activity was increased greater than 2x, while the CD47 KO 
group showed no change from WT control. Application of the antioxidant/NOX1 inhibitor 
apocynin rescued normal adhesion and rolling counts in the WT + MWCNT group. No 
differences were observed in blood O2●- levels as measured by EPR with the 
hydroxylamine spin probe, 1-hydroxy-4-phosphono-oxy-2,2,6,6-tetramethylpiperidine 
(PPH). Lung and plasma nitrate and nitrite (NO2- and NO3-, NOx) were reduced in the WT 
+ MWCNT group by 47% and 32%, respectively, while the CD47 KO group were 
unchanged from control. No differences were observed in either WT group with the 
biomarkers of inflammation we assessed, however, several pro-inflammatory cytokines 
were altered in the CD47 + MWCNT group; Lung IL-6, gluteus TNF-α, plasma IL-6, IL-
10, VEGF, and TNF-α were all upregulated, while lung VEGF was decreased. 
These findings support the evidence that TSP-1 is an important ligand mediating 
MWCNT-induced microvascular dysfunction, and demonstrate that CD47 receptor is a key 
component of this dysregulation. In this model, CD47 activation likely disrupts NO 
signaling and promotes leukocyte-endothelial interactions. Impaired NO production, 
signaling, and bioavailability is etiologically linked to a variety of cardiovascular diseases. 
As such, the relevance of these results may not necessarily be limited only to vascular 
effects following pulmonary particular matter exposure, but possibly other pathologies 




Engineered nanomaterials (ENM) are rapidly becoming an integral component of 
modern composite material manufacturing. Nanomaterials may be comprised of a wide 
range of chemical compositions and molecular structures, but by definition they must 
possess at least one dimension less than 100 nm. This small scale provides advantages 
for manufacturing but nanomaterials are also more readily aerosolized and deposited into 
the deep lung upon inhalation, making them more dangerous than the same materials of 
larger particle size (Bakand et al., 2012). Of particular concern is a class of ENM known 
as multi-walled carbon nanotubes (MWNCT). While fairly heterogeneous in 
physicochemical properties (e.g. aspect ratio, metal contamination, attached function 
groups) all MWCNT are comprised of layers of graphene arranged in concentric tubes. 
Pulmonary symptoms of exposure to most MWCNT species include increased neutrophil 
influx, genotoxicity, lymphocytic aggregates, and fibrosis (Mercer et al., 2011) 
There is evidence that in addition to direct damage to pulmonary tissue, exposure 
to nanomaterials is capable of generating deleterious systemic effects. The anti-
vasodilatory effect for this route of exposure in arterioles has been previously established 
(LeBlanc et al., 2009, Nurkiewicz et al., 2009). As a primary source of peripheral 
resistance and control of tissue perfusion, the arterioles play a critical role in contributing 
to the maintenance of homeostasis and are responsive to a variety of chemical, neural, 
and physical inputs. The balance of these various inputs results in a physiological 
response of vasodilation or vasoconstriction achieved via changes in smooth muscle 
contraction or relaxation. Inability to control arteriolar diameter, and especially the ability 
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to dilate appropriately, has been associated with a variety of serious disease states, 
including hypertension (Perticone et al., 2001, Petrak et al., 2006), peripheral/coronary 
artery disease (Heitzer et al., 2001, Brevetti et al., 2008), and atherosclerosis (Bonetti et 
al., 2003, Davignon and Ganz, 2004, Sitia et al., 2010). Pulmonary MWCNT exposure has 
been linked to each of the above conditions (Stapleton et al., 2012a, Cao et al., 2014, 
Thompson et al., 2014, Aragon et al., 2016, Han, 2016).  
The molecular mechanisms linking pulmonary MWCNT exposure to microvascular 
dysfunction have yet to be fully elucidated. Among several putative pathways, one is that 
the innate immune response triggered in the lung activates and releases vasoactive 
factors which are then distributed systemically through the circulation. Acute lung injury 
and inflammation promotes macrophage influx, leukocyte adhesion (Inoue et al., 2009), 
and the formation of leukocyte-platelet aggregates (Zarbock and Ley, 2009). The 
matricellular matrix protein thrombospondin-1 (TSP-1) is a major component of the α-
granules of platelets, and is released upon platelet activation (Baenzige.Nl et al., 1971). 
We have recently demonstrated that pulmonary exposure to MWCNT resulted in 
increased peripheral TSP-1 protein in wildtype C57B6J background mice, along with 
reduced arteriolar dilatory capacity, and increased leukocyte venular adhesion and rolling 
(Mandler et al., 2017). TSP-1 knockout mice exposed to MWCNT were protected from the 
negative changes in arteriolar reactivity experienced by wildtype control animals.  TSP-1 
elevation and impaired vascular function following MWCNT exposure have also recently 
been observed by another group (Aragon et al., 2016, Aragon et al., 2017). 
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TSP-1 is capable of influencing vessel diameter via several distinct pathways. In 
particular, TSP-1 inhibits nitric oxide (NO) and cGMP signaling through the cell surface 
receptor CD47, which inhibits soluble guanylate cyclase (sGC) (Isenberg et al., 2005b). 
At picomolar concentrations, TSP-1 is capable of completely inhibiting NO-stimulated 
production of cGMP by sGC, thus limiting vascular smooth muscle relaxation (Isenberg et 
al., 2006b). CD47 signaling is also capable of causing eNOS uncoupling and generation 
of ROS (Bauer et al., 2012). In addition to directly inhibiting NO signaling and production, 
it is also possible that TSP-1 may indirectly influence arteriolar diameter by promoting the 
recruitment of leukocytes to the endothelium through activation of intracellular and 
vascular adhesion molecules (ICAM-1, VCAM-1) (Narizhneva et al., 2005). As these 
activated leukocytes adhere, roll, flatten, and undergo trans-endothelial migration, 
production of superoxide by NADPH-oxidase can quench NO as it is produced, reducing 
its bioavailability (Hopps et al., 2009). Superoxide is rapidly converted to H2O2 by 
superoxide dismutase, and may exert effects on vascular reactivity independent of NO 
(Bauer et al., 2012, Knuckles et al., 2013). Local oxidative and nitrositive stress are 
hallmarks of leukocyte endothelial interactions (Kar and Kavdia, 2012).  
While the evidence for the role of TSP-1 as a key mediator in the pathophysiology 
of microvasculature dysfunction following nanomaterial exposure is strong, the relative 
contribution of various pathways have yet to be determined. Additionally, the upstream 
signals of TSP-1 in the lung, circulation, and skeletal muscle in this context are unclear. 
The objective of the current work is to determine the role of CD47 in following pulmonary 
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MWCNT exposure, identify potential inflammatory regulators of TSP-1, and measure 




C57BL/6J background Cd47tm1Fpl (CD47 KO) and wild-type (WT) were purchased 
from Jackson Labs, Bar Harbor, ME (Stock# 003173 and 000664, respectively). Mice were 
handled according to NIH Use of Laboratory Animals, Animal Welfare Act, and all 
experiments were approved by the West Virginia University Institutional Animal Care and 
Use Committee. Mice were kept on a 12-hour light/dark cycle, and provided food and tap 
water ad libitum.  Experiments were scheduled so that data collection occurred at 
approximately 16 weeks of age. At this age, the mice are sexually and developmentally 
mature and the gluteus maximus muscle is of sufficient size and strength to undergo 
intravital microscopy (Flurkey et al., 2007). Both male and female WT and KO animals 
were used in all experiments in approximately equal numbers (Table 1).  
Nanomaterial exposure details 
MWCNT are catalytically grown by chemical vapor deposition processes and were 
obtained from Mitsui & Co (MWNT-7, Lot # 061220-31, Ibaraki, Japan). Mitsui-7 MWCNTs 
were designated as the ENM of choice for this project based on the wide number of 
potential applications, observed toxicity, and prior investigations by our group (Porter et 
al., 2010, Mandler et al., 2017). Oropharyngeal aspiration, as opposed to intratracheal 
instillation or aerosol inhalation was chosen as the method of exposure for this study due 
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to the high degree of flexibility and scalability compared to inhalation, and is less 
traumatic for the animals than intratracheal instillation (Rao et al., 2003). Prior studies 
have shown that aspiration of this dose of MWCNT in dispersion medium (DM) generates 
pulmonary response analogous to instillation (Bonner et al., 2013) and inhalation 
(Shvedova et al., 2008, Mercer et al., 2011). In brief, prior to aspiration, 50 μg MWCNT 
is suspended and dispersed in a phospho-buffered saline/purified mouse serum albumin 
(PBS/MSA) medium using ultrasonication.  While anesthetized (isoflurane), the solution 
is placed in the oropharynx with the tongue manually extended. Upon release, the tongue 
retracts and the mouse reflexively inhales, aspirating the material and depositing in the 
lung (Rao et al., 2003). This dose and delivery method has previously been shown to 
induce lung injury and inflammation (Porter et al., 2010). Control animals received a sham 
aspiration of medium without nanomaterials. This DM has been shown to be both 
biocompatible, non-immunogenic, and effective at dispersing MWCNT (Porter et al., 2008, 
Porter et al., 2010). 
 
Intravital microscopy and iontophoresis of mouse gluteus maximus arterioles 
At 24-h post-aspiration, KO or WT mice were anesthetized using thiobutabarbital 
(Inactin, 100 mg/kg, i.p.) and placed on a thermo-probe regulated heating pad to 
maintain a 37 °C core temperature. The trachea was intubated to ensure a patent airway. 
The right gluteus maximus muscle was surgically exteriorized for microscopic observation, 
leaving its innervation and all feed vessels intact. This site of observation was chosen as 
skeletal muscle is the largest global reservoir of the microvasculature and the largest 
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source of active peripheral resistance. After exteriorization, the muscle was secured over 
an optical pedestal with 5-0 suture wire at its in situ length. The pedestal was sealed with 
stopcock grease to create a superfusate bath. Throughout the surgery and following 
experimental period, the muscle was continuously superfused with an electrolyte solution 
(119 mM NaCl, 25 mM NaHCO3, 6 mM KCl, and 3.6 mM CaCl2), warmed to 35 °C, and 
equilibrated with 95% N2–5% CO2 (pH = 7.35–7.40). Superfusate flow rate was 
maintained at 4 ml/min to minimize equilibration with atmospheric oxygen. 
The animals were transferred to an intravital microscope coupled to a digital video 
camera. Observations were made with a 20X water immersion objective. A micropipette 
with an opening of 1-2 µm was filled with a 10-2 M acetylcholine (to measure endothelium 
dependent vasodilation) solutions. The tip of the pipette was guided under microscope to 
a point adjacent to the adventitia of the target arteriole. During this time a holding current 
of -200 nA or 200 nA, respectively, was applied to the bath to prevent ACh/SNP leakage 
from the pipette. Once in place and following a 20-minute equilibration period, ejection 
currents of 20 nA, 40 nA and 80 nA, and 120 nA (for ACh) were applied to the bath for 5 
minutes each in a randomized order, with a 5-minute washout period between each step. 
Following the final ACh washout period, adenosine was added to the superfusate at a 
concentration of 10-3 M to determine vessel maximal passive diameter. Images were 
displayed on a high-resolution computer monitor and digitally captured in the last minute 
of each step for later analysis using ImageJ (ImageJ 1.46v, National Institutes of Health). 
One to three first order arterioles were studied per mouse. Measurements of vessel 
diameter were made from recorded images. Vessel reactivity is reported as percent of 
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maximal diameter achieved. Resting vascular tone was calculated for each vessel as 
follows:𝑡𝑜𝑛𝑒 =  [
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑐
𝐷𝑝𝑎𝑠𝑠
] 𝑥 100, where D is arteriolar diameter, in micrometers, and 
Dpass is passive diameter under ADO, and Dc is the diameter measured during the control 
period. Dc was taken following a 20-minute equilibration and only if no change in vessel 
diameter had been observed for at least 1 minute prior. Percent relaxation was calculated 
at each ACh or SNP ejection current as follows:% 𝑟𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 =  [
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑖𝑜𝑛
𝐷𝑝𝑎𝑠𝑠 – 𝐷𝑐
]  𝑥 100, 
where Dion is the vessel diameter following 5 minutes of drug delivery via iontophoresis. 
 
Leukocyte adhesion and rolling 
     Leukocytes that were either stationary or moving but in constant contact with the 
venular wall for at least 200 µm were counted for 1 min in each venule studied. Following 
the completion of iontophoresis studies and after a 20-minute washout period, 10-4 M 
apocynin was added to the superfusate to examine contributions of reactive oxygen 
species. Following a 30 minute apocynin incubation period, the measurements were 
repeated.  
 
Tissue Redox Status 
      At the conclusion of intravital experiments, 100 µl of whole blood was collected from 
each experimental animal and incubated with the spin probe 4-phosphonooxy-2,2,6,6-
tetramethylpiperidine-N-hydroxyl (PPH) for 10 minutes at a final concentration of 0.25mM 
before being snap frozen for later analysis. Electron paramagnetic resonance was used 
to detect superoxide (O2●-) and in biologic samples, spectra were obtained EPR spectra 
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were obtained using a Bruker EMX EPR spectrometer equipped with a Bruker ER4119 HS 
resonator. Samples were prepared in 1.5 ml plastic centrifuge tubes and were transferred 
to a quartz flat cell (Wilmad Glass Co, Buena, NJ) before spectra were obtained. 
Superoxide levels were estimated from the magnitude of the downfield peak height of 
the 3-line nitrogen hyperfine as well as the area under the curve and were expressed in 
arbitrary units. Validation of superoxide was accomplished by the presence of SOD. 
 NO has an extremely short half-life in vivo and is rapidly converted to 
intermediates. Tissue NOx (nitrate + nitrite) was measured by first chemically reducing 
NOx to NO gas (0.05 M vanadium chloride (VCl3) in 1 M HCl at 92°C) as described by 
(Braman and Hendrix, 1989) and then detecting the light generated by reaction of NO 
gas with O3 using a Sievers 280i NO analyzer (NOA) (Boulder, CO). A 50 ml glass impinger 
vial containing 30 ml VCl3 (0.4 M in 1 M HCl) at 95 1C. Helium gas was bubbled through 
the impinger vial, a condenser, a water trap containing 10 ml NaOH, and was delivered 
to the NOA. A standard curve was generated (Liquid Program software v 3.22 PNN, 
Sievers) and used to calculate NO released by each injected sample. 25 µl samples were 
run in duplicate and chemiluminescence analyzed by the NOA. 
 
Tissue Inflammatory Markers 
Inflammatory cytokines (IL-6, IL1-β, IL-10, VEGF, TGF-β, and TNF-α) were quantified by 
U-Plex Meso Scale Discovery® multi-cytokine array (Meso Scale Diagnostics, 




Statistics and calculations 
A D'Agostino & Pearson omnibus normality test was used to assess homogeneity 
of variance. In cases where non-normal datasets were detected, statistical comparisons 
were made with Kruskal-Wallis tests and post-hoc Wilcoxon rank-sum tests for between 
subject effects where appropriate.  A 2 x 2 factorial ANOVA was performed to compare 
the main effects of exposure (sham vs MWCNT) and genotype (WT vs KO) for each 
variable.  When significant main effects were observed a Sidak post-hoc test was used to 
determine where significant differences existed between the groups. In all cases, p < 
0.05 was used to establish statistical significance.  All data are reported as mean  SEM, 
unless otherwise noted.  
 
Results 
Animal and baseline vessel characteristics 
No differences were observed between groups in age or weight (Table 1). Ratios 
of male to female animals used were equal or very close to equal. Arterioles examined in 
this study averaged approximately 34.5 µm in diameter across all group (Table 2). No 
differences between treatment groups were observed in baseline diameter, passive 
diameter, or resting tone (Table 2). There were also no significant sex differences in 






Arteriolar endothelium dependent reactivity 
 Arteriolar endothelium dependent reactivity was measured via intravital 
microscopy. ACh administration yielded a dose-dependent increase in WT + SHAM 
arterioles, reaching 89.6% of passive diameter at the highest ACh ejection current (Fig. 
1). The WT + MWCNT arterioles demonstrated impaired vasodilation at 40, 80 and 120 
nA ACh, achieving only 56.8% of passive diameter, an impairment of 32.8% compared 
to controls (Fig 1.). Vessels in CD47 KO animals exposed to MWCNT displayed no impaired 
ACh response, and even exceeded the control group at the 80nA level achieving 105.3% 
of passive diameter (Fig. 1). 
 
Venular leukocyte adhesion and rolling 
 The flux of leukocytes through target venules was assessed at baseline and 
following application of antioxidant/NOX1 inhibitor apocynin. MWCNT exposure increased 
leukocyte flux by 222% compared to WT control (Fig. 2). MWCNT exposure elicited no 
significant increase in leukocyte flux in the CD47KO group. Application of apocynin 
rescued normal leukocyte flux in the WT + MWCNT group and depressed values in the 
other groups (Fig. 2). 
 
Tissue Redox Status 
No differences between any groups were observed in O2●- content in whole blood 
using EPR with the spin probe agent PPH (Fig. 3).  Tissue NOx was assessed using a 
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Sievers NO analyzer. In the Lung, NOx was reduced by 47% in WT + MWCNT animals, 
compared to control, while NOx levels in CD47KO + MWCNT animals were not different 
from controls (Fig. 4). A similar pattern was observed in the plasma, with a 32.3% NOx 
reduction in WT + MWCNT animals and no change in the CD47KO + MWCNT group.  
 
Tissue Inflammatory Markers 
No differences in any measure were observed between WT groups, however 
several markers were different from control compared to the CD47KO + MWCNT group. 
In the lung, IL-6 was elevated and VEGF was depressed in CD47 + MWCNT animals. In 
the plasma, IL-6, IL-10, VEGF, and TNF-α were all elevated in CD47 KO + MWCNT animals 
compared to control and WT + MWCNT groups. In gluteus muscle tissue, VEGF was 
depressed, while TNF-α was enhanced in CD47 + MWCNT animals. No differences 





 The principal finding of this study is that the CD47 receptor plays a critical role in 
the vascular dysfunction associated with lung exposure to MWCNT. We observed that 
CD47KO + MWCNT animals exhibited similar, or even greater, levels of arteriolar 
endothelium-dependent vasodilation in response to ACh stimulation than WT+SHAM 
controls. TSP-1 normally circulates at a low (0.22nM), but vasoactive concentration 
(Csanyi et al., 2012) acting as a limiting factor to NO signaling. Removal of this “brake” 
influence through ablation of this signaling pathway. These findings closely resemble 
patterns dilation achieved by TSP-1KO animals in our previous work (Mandler et al., 
2017), as well as arterioles from CD47KO and TSP-1KO animals observed in other 
intravital microscopy experiments (Bauer et al., 2010). When exposed to MWCNT, 
CD47KO animals exhibited no decrease in dilatory capacity compared to WT animals, in 
which relaxation was impaired by 32.8%. The protection offered by CD47 knockout 
strongly suggests that CD47 is integral in mediating impairments following pulmonary 
MWCNT exposure.  
One mechanism through which MWCNT exposure ultimately exerts its effects on 
peripheral microvasculature presumably involves impairment of NO generation, signaling, 
and/or bioavailability. Although we did not detect any changes in O2●- levels using EPR 
(perhaps due to the abundance of heme, free iron and protein in blood), our NOA results 
suggest that NO is depressed in lung and plasma following MWCNT, and that CD47 KO 
animals are protected from this effect. The failure to observe a difference in the skeletal 
muscle may be explained by the much smaller portion of tissue in contact with the 
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circulatory system in the skeletal muscle, compared to the plasma or lung. Our leukocyte 
adhesion analysis may also yield some additional information on vessel ROS status. CD47 
signaling is capable of activating NADPH oxidase-1 (NOX1) in, both, the endothelium 
(Csanyi et al., 2012) and circulating leukocyte (Barclay, 2009). Generating ROS promotes 
leukocyte adhesion through P-selectin mobilization (Granger and Senchenkova, 2010b). 
CD47 signaling also promotes leukocyte adhesion through ICAM-1/VCAM-1 activation 
(Lagadec et al., 2003, Narizhneva et al., 2005), which in turn activates NOX1 within 
minutes (Deem and Cook-Mills, 2004), and promotes endothelial disorganization and 
permeability (DelMaschio et al., 1996). CD47 KO animals have reduced leukocyte 
recruitment into dermal air pouches, and reduced transmigration even when stimulated 
with TNF-α. (Azcutia et al., 2012).  In this study, CD47KO animals did not exhibit 
increased leukocyte flux following MWCNT exposure (compared to WT animals), and 
application of apocynin (an antioxidant/NOX1 inhibitor) rescued normal leukocyte flux in 
the WT + MWCNT group, and reduced levels to below PSS alone in WT + SHAM and 
CD47KO + MWCNT groups. Pulmonary nanoparticle exposure generates oxidative and 
nitrositive stress in the microvascular wall (Nurkiewicz et al., 2009, LeBlanc et al., 2010), 
our findings suggest that TSP-1/CD47 signaling contribute to this effect and promote 
endothelial cell adhesion and transmigration, which can further exacerbate endothelial 
dysfunction. 
Aragon et al. have recently investigated the contributions of another TSP-1 
receptor, CD36, to MWCNT-exposure induced vascular dysfunction (Aragon et al., 2016, 
Aragon et al., 2017). The authors observed that CD36KO aortic rings did not exhibit 
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significant reductions in vasodilation reactivity following incubation in serum collected 
from MWCNT-exposed mice, despite increase in circulating TSP-1 protein, in contrast with 
WT aortas which were dramatically impaired at 4 and 24 hrs. post-exposure. In WT aortas 
incubated in serum from matrix metalloproteinase-9 (MMP-9) KO animals exposed to 
MWCNT, no significant impairment was noted. The authors postulate an MMP-9/TSP-
1/CD36 signaling axis mediates vascular impairments. More investigation is necessary to 
reconcile the findings of Aragon et al. with our work with TSP-1 and CD47KO animals. It 
is possible that ablation of a single TSP-1 signaling axis is sufficient to offer protection. It 
is important to note, however, significant differences in methodology that may account 
for differences in signaling pathways activated. Aragon et al. 2016, utilized an isolated ex 
vivo wire myographic preparation of mouse aorta segments. While certainly a valid and 
useful tool for explorations of vascular function, this technique differs in several important 
ways from our work. In the present study, the use of an in vivo preparation allowed for 
the examination of vessels as they actively function, not removed from neural, 
mechanical, and humoral inputs and without pre-constriction. Secondly, the aorta differs 
fundamentally in form and function from the resistance vasculature, so comparisons 
made between the two are limited by these factors. To reconcile our findings with those 
of Aragon et al., it will be necessary to perform similar in vivo intravital investigations of 
the arterioles of CD36KO mice following MWCNT exposure. Indeed, future research is 
warranted to determine the relative contributions of CD47 vs. CD36, as well as which 
downstream targets are predominantly responsible for microvascular dysfunction. 
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Acute single exposure to MWCNT has been associated with pulmonary 
inflammation at the 24 hr timepoint as assesed by BAL (polymorphonucleocyte count, 
albumin, lactate dehyrdoginase conent) (Porter et al., 2010). Some studies have found 
that BAL fluid and macrophages have elevated inflammatory cytokines (including TNFα, 
IL-6, IL-1α, and IL-1β), as well as other markers of inflammation, such as lactate 
dehydrogenase, mucin, and surfactant protein-D (SP-D) at day 1 post MWCNT exposure 
(Han et al., 2010, Dong et al., 2015). IL1-β and IL-18 secretion has also been shown to 
be stimulated by exposure to raw or functionalized MWCNT in cultured macrophages 
(Hamilton et al., 2013). In this study, we saw no significant difference tissue or circulating 
cytokines between MWCNT and sham exposed WT groups. Other studies have also shown 
no changes in cytokine production following MWCNT exposure. Mitchell et al. observed 
no inflammation or changes in  lung mRNA IL-10 or IL-6 at 24 hours following MWCNT 
exposure (Mitchell et al., 2007). Elgrabli et al. observed that no changes in BAL mRNA in 
the lung for IL-1β, IL-6, IFNγ, COX2, and iNOS or protein levels for IL-1α, IL-1β, IL-2, IL-
4, IL-6, IFNγ, TNFα from 1 – 180 days post-MWCNT exposure (Elgrabli et al., 2008). At 
present, it is not clear why there are divergent responses, but most likely is due to 
differences in the methodology approaches and potentially the exposure paradigm. 
We did, however, observe changes in several cytokines in our CD47 KO animals 
followng MWCNT exposure (Fig. 5). CD47 engagement can limit cytokine secretion 
(Demeure et al., 2000), while CD47 blocking in macrophages has the opposite effect 
(Weiskopf et al., 2015). It is possible that the cytokine changes observed are simply due 
to this effect, and not a result of MWCNT exposure. A limitation of our intepretation is 
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the lack of an unexposed CD47KO group. Despite this, our results combined with those 
from other studies, allow us to make inferences about the role of the measured cytokines 
and their potential involvement in mediating peripheral endothelial dysfunction. The fact 
that in WT+MWCNT we observed no changes in cytokines in any tissues, but observed 
substantial inhibitions of vasodilation and increases in leukocyte adhesion, while in the 
CD47KO+MWCNT group the oppossite was true, strongly suggests that these cytokines, 
whether in the lung, circulation, or target organ are not playing a signicant role in 
mediating the observed microvascular dysfunction.  
In summary, 24 hours following pulmonary exposure to MWCNT, CD47KO animals 
exhibited no loss of vasodilatory function and no change in leukocyte-endothelial 
interaction that is found in WT animals. No alterations in blood ROS status were observed, 
however MWCNT exposure lowered lung and plasma NOx in WT animals while CD47KO 
were unnaffected. Inflammatory cytokines were unchanged in WT animals following 
exposure, while a significant shift in pro-inflammatory factors was observed in CD47KO 
animals. These data complement earlier findings that microvascular dysfunction following 
MWCNT was TSP-1 dependent, and indicate that TSP-1/CD47 axis is an important 
mediator involved in the vascular dysfunction associated with exposure to MWCNTs. Our 
results are not necessarily limited to microvascular dysfunction following pulmonary 
exposure to nanomaterial. Indeed, TSP-1/CD47 signaling is activated in many disease 
states, including pulmonary arterial hypertension (Bauer et al., 2012), peripheral and 
coronary artery disease (Smadja et al., 2011, Choi et al., 2012), inclusion body myositis 
(Salajegheh et al., 2007) and others. Therefore, it is reasonable to speculate that ENM 
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exposures which result in activation of this pathway may generate or exacerbate pre-
existing diseases. However, this must be directly tested in future studies. Therapuetic 
interventions aimed at the TSP-1/CD47 axis may help to reduce microvascular dysfunction 
not only in response to ENM exposure, but potentially other conditions that involve 
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Table 5.1. Animal Characteristics. No significant differences were observed 
between groups in age, weight or sex.   
  Animal Characteristics  
  WT+SHAM WT+MWCNT CD47 KO + MWCNT 
N total mice  
(male:female) 
14 15 6 
(7:7) (7:8) (3:3) 
Age (weeks) 16.5±0.6 16.4±0.5 16.1±0.2 





 Arteriole Characteristics 
  WT+SHAM WT+MWCNT CD47KO 
n (vessels) 21 15 8 
Baseline Diameter (µm) 34.4±2.4 34.9±2.0 34.4±2.8 
Passive Diameter (µm) 52.0±2.6 49.65±2.6 47.5±3.5 









Table 5.2 Baseline vessel characteristics. No significant differences 
were observed between exposure groups of vessels used for 
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Figure 5.1. Endothelium dependent vasodilation in gluteus maximus arterioles. 
Arteriolar dilation presented as percent of maximal passive dilation achieved 
with adenosine. (*) indicates difference (p < 0.05) from WT + Sham group. (†) 
Indicates difference from WT + MWCNT group (P < 0.05). Number of 
earterioles studied for each group is as follows: WT + SHAM (n = 21), WT + 












































































































Figure 5.2. Venular leukocyte adhesion and rolling activity. (*) indicates 
main effect for Apocynin (p < 0.05). (†) indicates difference from WT + 
SHAM with PSS (p < 0.05). (‡) Indicates difference from WT + MWCNT with 
PSS (p < 0.05). Number of venules studied for each group is as follows: WT 
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Figure 5.3 Blood reactive oxygen species content.  No differences between 
groups were observed in either 1
st
 peak height (A) or integrated peak area (B) in 
blood samples using EPR with the spin trap compound PPH. Number of animals 



















































































































































T is s u e   N O x
Figure 5.4 Tissue NOx. NOx was reduced in WT+MWCNT lung and plasma 
samples, compared to WT+ SHAM (*) (p < 0.05). NOx was elevated compared to 
WT+MWCNT in CD47KO+MWCNT lung and plasma (†) (p < 0.05) No differences in 
between any groups were observed in the gluteus maximus tissues. Number of 
animals studied: WT + SHAM (n = 14), WT + MWCNT (n = 5), CD47 KO + MWCNT 








































1 0 0 0
1 0 0 0 0
1 0 0 0 0 0
*






































1 0 0 0
1 0 0 0 0
*†













































































































































0 .0 0 0 0 1
0 .0 0 0 1
0 .0 0 1
0 .0 1



































1 0 0 0
*













































































































T is s u e   In f la m m a tio n  B io m a r k e rs





































































0 .0 0 0 1







Figure 5.5 Tissue Inflammation Biomarkers. (*) indicates difference from WT + 
SHAM group (p < 0.05). (†) Indicates difference from WT + MWCNT (p < 0.05). No 
differences were observed between groups in measured levels of or IL-1 Number of 
animals studied: WT + SHAM (n = 14), WT + MWCNT (n = 5), CD47 KO + MWCNT 








NO-mediated arteriolar reactivity plays a critical role in microvascular function and 
the maintenance of homeostasis. Dysregulation of this system is etiologically linked to a 
range of diverse pathologies including hypertension (Koller and Huang, 1994, Frisbee and 
Stepp, 2001) myocardial infarction (Michaels et al., 2000, Bolognese et al., 2004), 
Alzheimer’s (Iadecola et al., 1999), and other vascular diseases (Hatoum et al., 2003). 
Pulmonary exposure to particulate matter and engineered nanomaterials has been shown 
to cause impairments of microvascular function. One mechanism responsible for these 
effects appears to be impairments of NO signaling and a shift towards oxidative stress 
(LeBlanc et al., 2009, Nurkiewicz et al., 2009, Stapleton et al., 2012). The work presented 
in Chapters 3 and 4 represent one of the first attempts to identify molecular pathways 
linking ENM-induced lung injury to peripheral vascular effects.  
AIM 1 
In order to properly investigate the molecular pathways activated by MWCNT 
exposure, it was necessary to first establish baseline arteriolar reactivity curves for the 
gluteus maximus arterioles using intravital microscopy in wildtype and KO animals. 
Previous investigations of the effects of particulate matter exposure on the 
microvasculature have typically used rats in tissues including the spinotrapezius  
(Nurkiewicz et al., 2004, Nurkiewicz et al., 2006, Nurkiewicz et al., 2008, Nurkiewicz et 
al., 2009, Knuckles et al., 2013), and uterine arterioles (Stapleton et al., 2015b). 
Compared to mice, rats have the practical advantages of greater tissue size and tolerance 
of invasive surgical procedures. However, availability of KO rats is limited and does not 
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include the genes of interest for this study. In order to probe the function of TSP-1 and 
CD47 in the context of MWCNT exposure, it was necessary to use a mouse preparation.  
Intravital microscopy of the mouse gluteus maximus arterioles was first developed 
by the Segal group and has since been utilized by them and others to study various 
aspects of microvascular function, especially changes with ageing (Bearden et al., 2004, 
Sinkler and Segal, 2014) both with iontophoresis (Bagher et al., 2011) and by adding 
vasoactive drugs to the entire superfusate solution (Givvimani et al., 2013). Iontophoresis 
offers several advantages over superfusate-wide dosing. Localized delivery allows 
reactivity to be studied at discrete locations and at specific orders within the microvascular 
network. This technique helps eliminate as confounding variables dramatic changes in 
blood flow, tissue perfusion, reflexive changes in blood pressure, thus exposing only the 
vasomotor properties of the target vessel.  It is important to note that precise 
quantification of the amount of drug delivered is difficult to describe accurately, however 
the vessels consistently respond in an ejection current-dependent manner.  
To date, there have only been a handful of studies utilizing intravital microscopy 
in transgenic or KO mice to study the microvasculature following lung particulate matter 
exposure (Sun et al., 2009, Xu et al., 2010, Kampfrath et al., 2011, Xu et al., 2012). 
These studies were conducted in the cremaster muscle, the animals were exposed to fine 
particulate matter (PM2.5), where NOX2, TLR4, and p47(phos) were the genetic targets. 
The authors in these cases only investigated venular leukocyte adhesion and rolling 
activity. To our knowledge, the work presented in chapters 3 and 4 represent the first 
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efforts to examine changes in arteriolar reactivity following pulmonary exposure to 
particulate matter in KO animals using this technique.  
Our sham exposed TSP-1 and CD47 KO animals demonstrated enhanced 
vasodilation compared to WT controls reaching 130% and 112% of passive dilation 
achieved with adenosine (CD47 Sham unpublished data, n = 2). The ability of the TSP-1 
KO animals to achieve greater dilation is likely due to the anti-dilatory effects of TSP-
1/CD36 signaling still present in the CD47 KO mice. TSP-1 and CD47 KO arterial relaxation 
has been examined previously (Bauer et al., 2010). In that study, the authors observed 
125 and 100% relaxation in TSP-1 and CD47 KO aortic rings, respectively. Comparisons 
between the observations of Bauer et al. 2010 in ex vivo wire myography preparations of 
mice aorta sections and our in vivo IVM work are of somewhat limited value due to the 
differences in preparation and drug delivery (iontophoresis vs. superfusate). In 
preliminary experiments not using iontophoresis, we observed that TSP-1 KO arterioles 
demonstrated only 98% of maximal passive diameter at a superfusate bath ACh 
concentration of 10-5 M (Mandler et al., 2014). The differences between vessel dilation at 
similar [ACh] is likely caused by vasodilation of the entire vascular bed, leading to 
increased blood flow and shear stress, or reflexive sympathetic outflow present in our 
preparation that is absent in isolated vessel experiments.  
One limitation of this work is the lack of blood pressure data for these experiments. 
The operational time frame available during this IVM procedure in mice is limited (~2 
hrs.), in order to maximize the amount of time available for measurement of arteriolar 
reactivity, blood pressure measurements were excluded. Future in vivo work should 
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include pressure measurements as a matter of completeness, if possible. However,  
previous experiments have failed to show changes in mean arterial pressure after a single 
MWCNT exposure (Stapleton et al., 2012), so we do not believe that the lack of blood 
pressure would alter our interpretation of the data we obtained.  
AIM 2 
Having successfully demonstrated that our TSP-1 and CD47 KO gluteus maximus 
experimental prep correlates well with other ex vivo investigations of TSP-1 and CD47 KO 
vessel reactivity and established a functional baseline, we could now investigate vessel 
responses following MWCNT exposure.  Our first objective was to determine the role of 
TSP-1. Elevated TSP-1 protein levels are associated with a variety of diseases in which 
deficits in NO production, bioavailability, and signaling play important roles, including PAH 
(Morrell et al., 2009, Labrousse-Arias et al., 2016), PAD (Brevetti et al., 2008, Smadja et 
al., 2011, Meller et al., 2013), CAD (Choi et al., 2012, Meller et al., 2013), diabetes 
(Stenina et al., 2003, Varma et al., 2008, Maier et al., 2010, Matsuo et al., 2015), and 
others. In preliminary experiments we observed increases in skeletal muscle TSP-1 levels 
in mice 24 hrs. following 2.5, 10, and 40 µg MWCNT aspiration exposures. We also 
observed TSP-1 protein increases in rat skeletal muscle 24hrs post MWCNT inhalation 
exposures, but not after Cerium Oxide nanoparticle inhalation (Mandler et al., 2014). In 
Chapter 3, we observed a greater than fivefold increase in TSP-1 protein in WT mouse 
skeletal muscle after MWCNT aspiration (Mandler et al., 2017). Our observations were 
recently confirmed by Aragon et al. (Aragon et al., 2017). The authors observed 
significant increases in serum TSP-1 protein as well as dramatic increases in mRNA 
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expression of several pro-inflammatory genes. TSP-1 elevation was associated with 
increased blood brain barrier permeability and neuroinflammation, which was ablated in 
TSP-1 receptor CD36 knockout animals. Taken in the context of earlier work linking CD36 
KO with protection from MWCNT induced vascular reactivity, it is highly suggestive that 
TSP-1 is a mediator of this process. While TSP-1 has yet to be investigated in the context 
of other particulate matter exposure, it seems likely that in light of these findings that 
TSP-1 may be implicated in many instances where lung injury and inflammation occur.  
We observed significant impairment in both endothelium-dependent (via ACh) and 
independent vasodilation (via SNP) vasodilation 24 hrs. post-MWCNT exposure in WT 
animals, suggesting impairments in both endothelium-dependent NO signaling as well as 
smooth muscle NO sensitivity. Alterations in reactivity to ACh or the calcium ionophore 
A23187 have been observed previously following MWCNT exposure, however our 
observation of reduced NO sensitivity are in contrast to several studies (Nurkiewicz et al., 
2009, Stapleton et al., 2012). Differences observed between our SNP results and these 
are likely due to differences in experimental species or vascular bed, although more 
investigation into this question is warranted. In our TSP-1 KO animals, no impairment of 
ACh or SNP mediated vasodilation was observed at any ejection current level. These 
findings represent the first implication of TSP-1 in mediating alterations in arteriolar 
dilation following MWCNT exposure.  
AIM 3 
Identifying TSP-1 as a mediator of MWCNT-induced microvascular dysfunction is 
an important step in understanding of this phenomena. However, to eventually be able 
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to treat or prevent it, it is necessary to further deepen our knowledge regarding the 
mechanisms through which TSP-1 influences microvascular reactivity following pulmonary 
MWCNT exposure. To better understand the regulatory role TSP-1 exerts on the 
microvasculature, we sought to investigate the role of the TSP-1 receptor CD47. 
Investigations of microvascular dysfunction post-nanomaterial inhalation strongly 
suggested that alterations in NO signaling and redox status were involved (Nurkiewicz et 
al., 2009, LeBlanc et al., 2010). With this information and knowing the involvement of 
CD47 in diseases associated with inflammation (Narizhneva et al., 2005, Salajegheh et 
al., 2005, Salajegheh et al., 2007) and NO disruption (Isenberg et al., 2008a, Isenberg 
et al., 2008c, Isenberg et al., 2009b, Bauer et al., 2010), we sought to investigate its role 
by utilizing CD47 KO mice for intravital and molecular experiments. Using the same 
intravital preparation as in Chapter 3, in Chapter 4 we measured arteriolar response to 
ACh in CD47 KO animals and observed a similar protection from MWCNT-induced 
impairment in vasodilation as in experiments with TSP-1 KO animals.  Unfortunately, we 
were unable to obtain additional CD47 KO mice in which to conduct SNP experiments to 
test NO sensitivity. This is a limitation of this work, however there is little reason to expect 
them to behave differently from the TSP-1 KO mice, as the preserved TSP-1/CD36 
signaling in the CD47KO animals has little direct impact on smooth muscle sGC activity 
(Isenberg et al., 2007). 
TSP-1/CD47 signaling enhances leukocyte endothelial interaction through 
ICAM/VCAM activation (Narizhneva et al., 2005). We observed a more than two-fold 
increase in adhered or rolling leukocytes in venules in WT animals exposed to MWCNT. 
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When apocynin was applied normal rolling activity was rescued. VCAM may also be 
upregulated by ROS stress (Deem and Cook-Mills, 2004). We also observed decreased 
tissue NOx in the WT + MWCNT group using the Sievers NO analyzer, while the opposite 
was true for CD47 and TSP1 KO animals. We were unable, however, to detect changes 
in blood ROS (using PPH spin trapping). Understood in the context of decreased NO 
mediated vasodilation observed in the WT + MWCNT, these findings are suggestive of 
decreased NO bioavailability, either due to depressed NO production, enhanced NO 
quenching by free radicals generated by NOX and eNOS uncoupling, or a combination of 
both being mediated by TSP-1/CD47 signaling.  
Finally, in chapter 4 we also attempted to analyze tissue biomarkers of 
inflammation from the lung, into the circulation, and in the gluteus maximus tissue. The 
lack of significant differences between WT Sham and MWCNT groups is in contrast with 
some studies that have identified the same cytokines as elevated in the circulation and 
BAL fluid (Inoue et al., 2009, Han et al., 2010, Porter et al., 2010, Dong et al., 2015), but 
in agreement with others that have found no change (Mitchell et al., 2007, Elgrabli et al., 
2008). It is possible that circulating inflammatory cytokines are generally higher in CD47 
KO animals, possibly due to the anti-inflammatory role of TSP-1/CD47 interactions. CD47, 
TSP-1, and TSP-2 KO mice sustain some inflammatory responses to a greater degree 
than WT counterparts (Lamy et al., 2007) and CD47 signaling may inhibit cytokine 
production (Demeure et al., 2000). It may also be the case that CD47 KO animals have 
a similar cytokine response but differ temporaly from WT animals. Further investigation 
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with a CD47 + Sham group and at different time points is warranted to provide more 
information about this question.   
Future Directions 
For as many questions as this project answers regarding the molecular 
mechanisms of microvascular dysfunction following MWCNT exposure, it raises even more 
to be answered in the future. The most obvious route of continued investigation would 
be further defining and characterizing the molecular pathways involved in the observed 
dysfunction. The observations of Aragon et al. 2017 suggest that CD36 is the necessary 
receptor for TSP-1 to exert influence on arterial reactivity. This raises a number of 
possibilities in terms of reconciling these findings with our work. However, our 
observation in chapter 3 that WT animals have reduced sensitivity to exogenously 
supplied NO suggests that CD47-mediated disruption of sGC activity is at least partly 
responsible for the observed dysfunction. It is possible that inhibition of either CD36 or 
CD47 is sufficient to offer vasoprotection. Owing to the different tissues observed 
between these studies (aorta vs. arterioles) it possible that CD36 signaling predominates 
in the compliance vessels, while CD47 is responsible for altering NO signaling in the 
arterioles. It may also be the case that in isolated vessels CD36 signaling is more effective, 
or the opposite is the case for CD47. To resolve the question of relative contribution 
between receptors, it would be valuable to evaluate endothelium dependent arteriolar 
responsiveness using intravital experiments on CD36 KO arterioles. Alternatively, in WT 
animals, oligonucleotides, peptides, siRNA, or other drugs could be delivered 
intravenously to block CD36 or CD47 signaling, possibly allowing for repeated measures 
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comparisons between reactivity in the same animal (Isenberg et al., 2008b, Wang et al., 
2013, Mansor et al., 2017). Once the contribution of receptors is determined it would 
next be advantageous to establish which downstream targets are most susceptible to 
disruption by CD47/CD36 signaling after MWCNT exposure. 
The relationship between physico-chemical properties of the chosen particulate 
matter for exposure to TSP-1 is another potential area for investigations. Our findings of 
elevated peripheral TSP-1 following MWCNT exposure, but not following nano-CeO2, 
suggest that differences in size, aspect ratio, reactivity, chemical composition, and 
functionalization may differentially activate this signaling pathway. It would therefore be 
valuable to measure TSP-1 in tissues collected from a wide variety of nanomaterials. 
Observed protein levels could be compared to the properties of each material to search 
for potential correlations. Ultimately, this knowledge could be used to increase the safety 
of given nanomaterials by constraining their physical characteristics or by adding surface 
modifications to be less toxic.  
The observations made in chapters 3 and 4 are limited to the 24-hour post-
exposure time point following a single MWCNT exposure. TSP-1 and arteriolar function 
should be measured in more occupationally-relevant chronic exposure regimen to truly 
assess the long term health effects. Chronic elevation of TSP-1 is associated with 
decreased skeletal muscle capillarity (Audet et al., 2013) as well as other cardiovascular 
pathologies (Roth et al., 1998, Maier et al., 2010, Choi et al., 2012). It is possible that 
chronic MWCNT exposure and TSP-1 elevation may exacerbate many of these diseases.  
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These studies used the relatively large single dose of 50 ug, which is roughly 
equivalent to an entire career’s worth of accumulated MWCNT exposure (Porter et al., 
2010). In preliminary experiments, we also observed significant increases in peripheral 
TSP-1 after MWCNT aspiration of as little as 2.5 µg / mouse (compared to 50 µg used in 
chapters 3 and 4). To better understand the role of TSP-1 in this context, it is necessary 
to develop a dose-dependent relationship between MWCNT exposure level, tissue TSP-1 
protein, and impairments of microvascular function. It is possible that there is a “safe” 
threshold of exposure to these materials that do not elicit a TSP-1 response. In addition 
to altering the dose of raw mitsui-7 MWCNT, it may also be worthwhile to investigate the 
role of MWCNT functionalization—the chemical addition of various hydrophilic groups that 
aid in solubility and dispersability—in generation of a TSP-1/CD47 response. Adding 
various functional groups, including COOH, NH2, and polyethylene glycol to the surface 
of MWCNT alters their physicochemical properties accordant pulmonary toxicity. 
Compared to raw MWCNT, functionalized MWNCT exposure may result in more, less, or 
roughly equal measures of lung toxicity (Li et al., 2013). Microvascular complications of 
exposure to these materials has seen little investigation, and it is possible that they may 
differentially elicit TSP-1/CD47 signaling compared to raw MWCNT.   
One pressing question that we were unable to answer is identifying the source of 
TSP-1 following MWCNT exposure. TSP-1, as discussed in Chapter 2, is a major 
component of platelets and makes up as much as 25% of all proteins secreted by 
activated platelets (Switalska et al., 1985) and enhanced levels in some cases of lung 
injury and inflammation (Idell et al., 1989). If activated platelets are one possible source 
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for secreted TSP-1 inhibiting platelet activation pharmacologically before and following 
MWCNT exposure should prevent a rise in TSP-1 levels. Choice of inhibitor in this case 
would be critical, as many have vasoactive side effects. If activated platelets are not a 
major source of TPS-1, the Campen group has postulated that elevated MMP9 activity 
following lung exposure results in extracellular matrix remodeling (Aragon et al., 2016). 
This remodeling process releases TSP-1 and possibly small CD36/CD47 binding peptides 
into the circulation, resulting in systemic effects. (Aragon et al., 2016). In these 
experiments the researchers observed increased MMP-9 in MWNCT-exposed lung tissue, 
and a degree of protection from impairments in ACh mediated vasodilation in vessels 
incubated in serum from MMP-9 KO mice, however they did not measure lung or 
circulating TSP-1 levels. If this hypothesis is correct, TSP-1 levels in MMP-9 animals 
exposed to MWCNT should be lower than comparable WT animals.  
Assuming that TSP-1 signaling truly is a mediator of microvascular dysfunction 
after MWCNT, inhibition of this pathway should offer WT animals a degree of protection 
comparable to TSP-1 and CD47 KO animals. Pharmacologic inhibition of TSP-1/CD47 
signaling has been shown to increase tissue blood flow, NO production, angiogenesis, 
and ischemic survival (Isenberg et al., 2009b). It is important to note, however that 
inhibition of TSP-1 signaling may have the unintended consequence of promoting 
angiogenesis and tumor growth (Lawler et al., 2001). It is possible that this effect may 
be largely CD36-dependent (Lawler, 2002). If it can be determined that only CD47 
signaling is necessary for MWCNT-induced impairments in arteriolar function, it may be 
preferable to target that receptor rather than inhibiting all TSP-1 signaling.  
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One important aspect of cardiovascular physiology that was not investigated in 
this dissertation is the contribution of autonomic nerve activity to altered vascular 
reactivity which may be altered by pulmonary nanomaterial exposure (Stapleton et al., 
2015a). The arterioles are innervated by postganglionic sympathetic neurons, which 
signal for vasoconstriction via the release of the catecholamine norepinephrine, which 
signals for vasoconstriction through smooth muscle α-adrenoceptors (Korthuis, 2011). 
Several measures of sympathetic outflow following pulmonary exposure to a variety of 
particulate matter have been investigated. Decreased heart rate variability, a measure of 
sympathetic outflow and decreased vagal tone, has been observed in workers exposed 
to PM2.5 and may persist for as long as 14 hours post-exposure (Cavallari et al., 2008a, 
Cavallari et al., 2008b). Pulmonary exposure to 10 µg of nano-TiO2 resulted in persistent 
sympathetically mediated arteriolar dysfunction as measured by active hyperemia in the 
presence of α-adrenergic blockade (Knuckles et al., 2013). TSP-1 can augment acute 
vascular responses to epinephrine (Isenberg et al., 2009a) and phenylephrine (Mandler 
et al., 2014). It is possible altered sympathetic outflow may be contributing to some of 
the TSP-1/CD47-driven arteriolar effects observed in chapters 3 and 4. It would be 
valuable to determine the contribution of sympathetic activity using pharmacologic agent 
such as phentolamine to block α-adrenergic receptor input in TSP-1 animals exposed to 
MWCNT. These experiments could be performed under baseline conditions as well as 
during iontophoretic stimulation using phenylephrine.   
 The findings presented this dissertation serve to further extend our knowledge of 
the molecular mechanisms underpinning the vascular consequences of pulmonary 
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exposure to particulate matter, an area of research that will be critical in fully 
understanding the toxicology of these materials. As discussed previously, our findings are 
limited to a single ENM species, route of exposure, and time point, but should serve as a 
foundation for future investigations examining these variables. Combined with the 
growing body of literature linking TSP-1/CD47 signaling to a variety of cardiovascular 
pathologies, our findings suggest that this signaling axis should be investigated 




Aragon, M., Erdely, A., Bishop, L., Salmen, R., Weaver, J., Liu, J., Hall, P., Eye, T., 
Kodali, V., Zeidler-Erdely, P., Stafflinger, J.E., Ottens, A.K. & Campen, M.J., 2016. 
Mmp-9-Dependent Serum-Borne Bioactivity Caused By Multiwalled Carbon 
Nanotube Exposure Induces Vascular Dysfunction Via The Cd36 Scavenger 
Receptor. Toxicological Sciences, 150, 488-498. 
Aragon, M.J., Topper, L., Tyler, C.R., Sanchez, B., Zychowski, K., Young, T., Herbert, 
G., Hall, P., Erdely, A., Eye, T., Bishop, L., Saunders, S.A., Muldoon, P.P., Ottens, 
A.K. & Campen, M.J., 2017. Serum-Borne Bioactivity Caused By Pulmonary 
Multiwalled Carbon Nanotubes Induces Neuroinflammation Via Blood–Brain 
Barrier Impairment. Proceedings Of The National Academy Of Sciences, 114, 
E1968. 
Audet, G.N., Fulks, D., Stricker, J.C. & Olfert, I.M., 2013. Chronic Delivery Of A 
Thrombospondin-1 Mimetic Decreases Skeletal Muscle Capillarity In Mice. Plos 
One, 8. 
Bagher, P., Polo-Parada, L. & Segal, S.S., 2011. Microiontophoresis And 
Micromanipulation For Intravital Fluorescence Imaging Of The Microcirculation. 
Journal Of Visualized Experiments : Jove. 
Bauer, E.M., Qin, Y., Miller, T.W., Bandle, R.W., Csanyi, G., Pagano, P.J., Bauer, P.M., 
Schnermann, J., Roberts, D.D. & Isenberg, J.S., 2010. Thrombospondin-1 
Supports Blood Pressure By Limiting Enos Activation And Endothelial-Dependent 
Vasorelaxation. Cardiovascular Research, 88, 471-481. 
Bearden, S.E., Payne, G.W., Chisty, A. & Segal, S.S., 2004. Arteriolar Network 
Architecture And Vasomotor Function With Ageing In Mouse Gluteus Maximus 
Muscle. Journal Of Physiology-London, 561, 535-545. 
158 
 
Bolognese, L., Carrabba, N., Parodi, G., Santoro, G.M., Buonamici, P., Cerisano, G. & 
Antoniucci, D., 2004. Impact Of Microvascular Dysfunction On Left Ventricular 
Remodeling And Long-Term Clinical Outcome After Primary Coronary Angioplasty 
For Acute Myocardial Infarction. Circulation, 109, 1121-1126. 
Brevetti, G., Schiano, V. & Chiariello, M., 2008. Endothelial Dysfunction: A Key To The 
Pathophysiology And Natural History Of Peripheral Arterial Disease? 
Atherosclerosis, 197, 1-11. 
Cavallari, J.M., Eisen, E.A., Fang, S.C., Schwartz, J., Hauser, R., Herrick, R.F. & 
Christiani, D.C., 2008a. Pm(2.5) Metal Exposures And Nocturnal Heart Rate 
Variability: A Panel Study Of Boilermaker Construction Workers. Environmental 
Health, 7. 
Cavallari, J.M., Fang, S.C., Eisen, E.A., Schwartz, J., Hauser, R., Herrick, R.F. & 
Christiani, D.C., 2008b. Time Course Of Heart Rate Variability Decline Following 
Particulate Matter Exposures In An Occupational Cohort. Inhalation Toxicology, 
20, 415-422. 
Choi, K.Y., Kim, D.B., Kim, M.J., Kwon, B.J., Chang, S.Y., Jang, S.W., Cho, E.J., Rho, 
T.H. & Kim, J.H., 2012. Higher Plasma Thrombospondin-1 Levels In Patients With 
Coronary Artery Disease And Diabetes Mellitus. Korean Circulation Journal, 42, 
100-106. 
Deem, T.L. & Cook-Mills, J.M., 2004. Vascular Cell Adhesion Molecule 1 (Vcam-1) 
Activation Of Endothelial Cell Matrix Metalloproteinases: Role Of Reactive Oxygen 
Species. Blood, 104, 2385-2393. 
Demeure, C.E., Tanaka, H., Mateo, V., Rubio, M., Delespesse, G. & Sarfati, M., 2000. 
Cd47 Engagement Inhibits Cytokine Production And Maturation Of Human 
Dendritic Cells. Journal Of Immunology, 164, 2193-2199. 
Dong, J., Porter, D.W., Batteli, L.A., Wolfarth, M.G., Richardson, D.L. & Ma, Q., 2015. 
Pathologic And Molecular Profiling Of Rapid-Onset Fibrosis And Inflammation 
Induced By Multi-Walled Carbon Nanotubes. Archives Of Toxicology, 89, 621-
633. 
Elgrabli, D., Abella-Gallart, S., Robidel, F., Rogerieux, F., Boczkowski, J. & Lacroix, G., 
2008. Induction Of Apoptosis And Absence Of Inflammation In Rat Lung After 
Intratracheal Instillation Of Multiwalled Carbon Nanotubes. Toxicology, 253, 131-
136. 
Frisbee, J.C. & Stepp, D.W., 2001. Impaired No-Dependent Dilation Of Skeletal Muscle 
Arterioles In Hypertensive Diabetic Obese Zucker Rats. American Journal Of 
Physiology-Heart And Circulatory Physiology, 281, H1304-H1311. 
Givvimani, S., Narayanan, N., Armaghan, F., Pushpakumar, S. & Tyagi, S.C., 2013. 
Attenuation Of Conducted Vasodilation In Skeletal Muscle Arterioles During 
Hyperhomocysteinemia. Pharmacology, 91, 287-296. 
Han, S.G., Andrews, R. & Gairola, C.G., 2010. Acute Pulmonary Response Of Mice To 
Multi-Wall Carbon Nanotubes. Inhalation Toxicology, 22, 340-347. 
Hatoum, O.A., Binion, D.G., Otterson, M.F. & Gutterman, D.D., 2003. Acquired 
Microvascular Dysfunction In Inflammatory Bowel Disease: Loss Of Nitric Oxide-
Mediated Vasodilation. Gastroenterology, 125, 58-69. 
159 
 
Iadecola, C., Zhang, F.Y., Niwa, K., Eckman, C., Turner, S.K., Fischer, E., Younkin, S., 
Borchelt, D.R., Hsiao, K.K. & Carlson, G.A., 1999. Sod1 Rescues Cerebral 
Endothelial Dysfunction In Mice Overexpressing Amyloid Precursor Protein. 
Nature Neuroscience, 2, 157-161. 
Idell, S., Maunder, R., Fein, A.M., Switalska, H.I., Tuszynski, G.P., Mclarty, J. & 
Niewiarowski, S., 1989. Platelet-Specific Alpha-Granule Proteins And 
Thrombospondin In Bronchoalveolar Lavage In The Adult Respiratory-Distress 
Syndrome. Chest, 96, 1125-1132. 
Inoue, K., Koike, E., Yanagisaw, R., Hirano, S., Nishikawa, M. & Takano, H., 2009. 
Effects Of Multi-Walled Carbon Nanotubes On A Murine Allergic Airway 
Inflammation Model. Toxicology And Applied Pharmacology, 237, 306-316. 
Isenberg, J.S., Frazier, W.A. & Roberts, D.D., 2008a. Thrombospondin-1: A 
Physiological Regulator Of Nitric Oxide Signaling. Cellular And Molecular Life 
Sciences, 65, 728-742. 
Isenberg, J.S., Jia, Y.F., Fukuyama, J., Switzer, C.H., Wink, D.A. & Roberts, D.D., 2007. 
Thrombospondin-1 Inhibits Nitric Oxide Signaling Via Cd36 By Inhibiting Myristic 
Acid Uptake. Journal Of Biological Chemistry, 282, 15404-15415. 
Isenberg, J.S., Pappan, L.K., Romeo, M.J., Abu-Asab, M., Tsokos, M., Wink, D.A., 
Frazier, W.A. & Roberts, D.D., 2008b. Blockade Of Thrombospondin-1-Cd47 
Interactions Prevents Necrosis Of Full Thickness Skin Grafts. Annals Of Surgery, 
247, 180-190. 
Isenberg, J.S., Qin, Y., Maxhimer, J.B., Sipes, J.M., Despres, D., Schnermann, J., 
Frazier, W.A. & Roberts, D.D., 2009a. Thrombospondin-1 And Cd47 Regulate 
Blood Pressure And Cardiac Responses To Vasoactive Stress. Matrix Biology, 28, 
110-119. 
Isenberg, J.S., Romeo, M.J., Yu, C., Yu, C.K., Nghiem, K., Monsale, J., Rick, M.E., Wink, 
D.A., Frazier, W.A. & Roberts, D.D., 2008c. Thrombospondin-1 Stimulates 
Platelet Aggregation By Blocking The Antithrombotic Activity Of Nitric 
Oxide/Cgmp Signaling. Blood, 111, 613-623. 
Isenberg, J.S., Shiva, S. & Gladwin, M., 2009b. Thrombospondin-1-Cd47 Blockade And 
Exogenous Nitrite Enhance Ischemic Tissue Survival, Blood Flow And 
Angiogenesis Via Coupled No-Cgmp Pathway Activation. Nitric Oxide-Biology And 
Chemistry, 21, 52-62. 
Kampfrath, T., Maiseyeu, A., Ying, Z.K., Shah, Z., Deiuliis, J.A., Xu, X.H., Kherada, N., 
Brook, R.D., Reddy, K.M., Padture, N.P., Parthasarathy, S., Chen, L.C., Moffatt-
Bruce, S., Sun, Q.H., Morawietz, H. & Rajagopalan, S., 2011. Chronic Fine 
Particulate Matter Exposure Induces Systemic Vascular Dysfunction Via Nadph 
Oxidase And Tlr4 Pathways. Circulation Research, 108, 716-U400. 
Knuckles, T.L., Stapleton, P.A., Minarchick, V.C., Esch, L., Mccawley, M., Hendryx, M. & 
Nurkiewicz, T.R., 2013. Air Pollution Particulate Matter Collected From An 
Appalachian Mountaintop Mining Site Induces Microvascular Dysfunction. 
Microcirculation, 20, 158-169. 
160 
 
Koller, A. & Huang, A., 1994. Impaired Nitric Oxide-Mediated Flow-Induced Dilation In 
Arterioles Of Spontaneously Hypertensive Rats. Circulation Research, 74, 416-
421. 
Korthuis, R., 2011. Regulation Of Vascular Tone In Skeletal Muscle. Skeletal Muscle 
Circulation. San Rafael, Ca: Morgan & Claypool Life Sciences. 
Labrousse-Arias, D., Castillo-Gonzalez, R., Rogers, N.M., Torres-Capelli, M., Barreira, B., 
Aragones, J., Cogolludo, A., Isenberg, J.S. & Calzada, M.J., 2016. Hif-2 Alpha-
Mediated Induction Of Pulmonary Thrombospondin-1 Contributes To Hypoxia-
Driven Vascular Remodelling And Vasoconstriction. Cardiovascular Research, 
109, 115-130. 
Lamy, L., Foussat, A., Brown, E., Bornstein, P., Ticchioni, M. & Bernard, A., 2007. 
Interactions Between Cd47 And Thrombospondin Reduce Inflammation. Journal 
Of Immunology, 178, 5930-5939. 
Lawler, J., 2002. Thrombospondin-1 As An Endogenous Inhibitor Of Angiogenesis And 
Tumor Growth. Journal Of Cellular And Molecular Medicine, 6, 1-12. 
Lawler, J., Miao, W.M., Duquette, M., Bouck, N., Bronson, R.T. & Hynes, R.O., 2001. 
Thrombospondin-1 Gene Expression Affects Survival And Tumor Spectrum Of 
P53-Deficient Mice. American Journal Of Pathology, 159, 1949-1956. 
Leblanc, A.J., Cumpston, J.L., Chen, B.T., Frazer, D., Castranova, V. & Nurkiewicz, T.R., 
2009. Nanoparticle Inhalation Impairs Endothelium-Dependent Vasodilation In 
Subepicardial Arterioles. Journal Of Toxicology And Environmental Health-Part A-
Current Issues, 72, 1576-1584. 
Leblanc, A.J., Moseley, A.M., Chen, B.T., Frazer, D., Castranova, V. & Nurkiewicz, T.R., 
2010. Nanoparticle Inhalation Impairs Coronary Microvascular Reactivity Via A 
Local Reactive Oxygen Species-Dependent Mechanism. Cardiovascular 
Toxicology, 10, 27-36. 
Li, R.B., Wang, X., Ji, Z.X., Sun, B.B., Zhang, H.Y., Chang, C.H., Lin, S.J., Meng, H., 
Liao, Y.P., Wang, M.Y., Li, Z.X., Hwang, A.A., Song, T.B., Xu, R., Yang, Y., Zink, 
J.I., Nel, A.E. & Xia, T., 2013. Surface Charge And Cellular Processing Of 
Covalently Functionalized Multiwall Carbon Nanotubes Determine Pulmonary 
Toxicity. Acs Nano, 7, 2352-2368. 
Maier, K.G., Han, X., Sadowitz, B., Gentile, K.L., Middleton, F.A. & Gahtan, V., 2010. 
Thrombospondin-1: A Proatherosclerotic Protein Augmented By Hyperglycemia. 
Journal Of Vascular Surgery, 51, 1238-1247. 
Mandler, W.K., Nurkiewicz, T. & Olfert, I.M., 2014. Thrombospondin-1 Null Mice Exhibit 
Enhanced Microvessel Endothelium Dependent Vasodilation, Reduced Adrenergic 
Sensitivity. Faseb Journal, 28. 
Mandler, W.K., Nurkiewicz, T.R., Porter, D.W. & Olfert, I.M., 2017. Thrombospondin-1 
Mediates Multi-Walled Carbon Nanotube Induced Impairment Of Arteriolar 
Dilation. Nanotoxicology, 11, 112-122. 
Mansor, L.S., Sousa Fialho, M.D.L., Yea, G., Coumans, W.A., West, J.A., Kerr, M., Carr, 
C.A., Luiken, J.J.F.P., Glatz, J.F.C., Evans, R.D., Griffin, J.L., Tyler, D.J., Clarke, 
K. & Heather, L.C., 2017. Inhibition Of Sarcolemmal Fat/Cd36 By Sulfo-N-
161 
 
Succinimidyl Oleate Rapidly Corrects Metabolism And Restores Function In The 
Diabetic Heart Following Hypoxia/Reoxygenation. Cardiovasc Res. 
Matsuo, Y., Tanaka, M., Yamakage, H., Sasaki, Y., Muranaka, K., Hata, H., Ikai, I., 
Shimatsu, A., Inoue, M., Chun, T.H. & Satoh-Asahara, N., 2015. Thrombospondin 
1 As A Novel Biological Marker Of Obesity And Metabolic Syndrome. Metabolism-
Clinical And Experimental, 64, 1490-1499. 
Meller, S.M., Stilp, E., Walker, C.N. & Mena-Hurtado, C., 2013. The Link Between 
Vasculogenic Erectile Dysfunction, Coronary Artery Disease, And Peripheral 
Artery Disease: Role Of Metabolic Factors And Endovascular Therapy. Journal Of 
Invasive Cardiology, 25, 313-319. 
Michaels, A.D., Gibson, C.M. & Barron, H.V., 2000. Microvascular Dysfunction In Acute 
Myocardial Infarction: Focus On The Roles Of Platelet And Inflammatory 
Mediators In The No-Reflow Phenomenon. American Journal Of Cardiology, 85, 
50b-60b. 
Mitchell, L.A., Gao, J., Wal, R.V., Gigliotti, A., Burchiel, S.W. & Mcdonald, J.D., 2007. 
Pulmonary And Systemic Immune Response To Inhaled Multiwalled Carbon 
Nanotubes. Toxicological Sciences, 100, 203-214. 
Morrell, N.W., Adnot, S., Archer, S.L., Dupuis, J., Jones, P.L., Maclean, M.R., Mcmurtry, 
I.F., Stenmark, K.R., Thistlethwaite, P.A., Weissmann, N., Yuan, J.X.J. & Weir, 
E.K., 2009. Cellular And Molecular Basis Of Pulmonary Arterial Hypertension. 
Journal Of The American College Of Cardiology, 54, S20-S31. 
Narizhneva, N.V., Razorenova, O.V., Podrez, E.A., Chen, J.H., Chandrasekharan, U.M., 
Dicorleto, P.E., Plow, E.F., Topol, E.J. & Byzova, T.V., 2005. Thrombospondin-1 
Up-Regulates Expression Of Cell Adhesion Molecules And Promotes Monocyte 
Binding To Endothelium. Faseb Journal, 19, 1158-+. 
Nurkiewicz, T.R., Porter, D.W., Barger, M., Castranova, V. & Boegehold, M.A., 2004. 
Particulate Matter Exposure Impairs Systemic Microvascular Endothelium-
Dependent Dilation. Environmental Health Perspectives, 112, 1299-1306. 
Nurkiewicz, T.R., Porter, D.W., Barger, M., Millecchia, L., Rao, K.M.K., Marvar, P.J., 
Hubbs, A.F., Castranova, V. & Boegehold, M.A., 2006. Systemic Microvascular 
Dysfunction And Inflammation After Pulmonary Particulate Matter Exposure. 
Environmental Health Perspectives, 114, 412-419. 
Nurkiewicz, T.R., Porter, D.W., Hubbs, A.F., Cumpston, J.L., Chen, B.T., Frazer, D.G. & 
Castranova, V., 2008. Nanoparticle Inhalation Augments Particle-Dependent 
Systemic Microvascular Dysfunction. Particle And Fibre Toxicology, 5. 
Nurkiewicz, T.R., Porter, D.W., Hubbs, A.F., Stone, S., Chen, B.T., Frazer, D.G., 
Boegehold, M.A. & Castranova, V., 2009. Pulmonary Nanoparticle Exposure 
Disrupts Systemic Microvascular Nitric Oxide Signaling. Toxicological Sciences, 
110, 191-203. 
Porter, D.W., Hubbs, A.F., Mercer, R.R., Wu, N.Q., Wolfarth, M.G., Sriram, K., Leonard, 
S., Battelli, L., Schwegler-Berry, D., Friend, S., Andrew, M., Chen, B.T., 
Tsuruoka, S., Endo, M. & Castranova, V., 2010. Mouse Pulmonary Dose- And 
Time Course-Responses Induced By Exposure To Multi-Walled Carbon 
Nanotubes. Toxicology, 269, 136-147. 
162 
 
Roth, J.J., Gahtan, V., Brown, J.L., Gerhard, C., Swami, V.K., Rothman, V.L., Tulenko, 
T.N. & Tuszynski, G.P., 1998. Thrombospondin-1 Is Elevated With Both Intimal 
Hyperplasia And Hypercholesterolemia. Journal Of Surgical Research, 74, 11-16. 
Salajegheh, M., Raju, R., Schmidt, J. & Dalakas, M.C., 2005. Thrombospondin-1 (Tsp1) 
And Its Binding Partners Cd36 And Cd47, As Mediators Of Inflammation In 
Sporadic Inclusion Body Myositis (Sibm). Neurology, 64, A158-A158. 
Salajegheh, M., Raju, R., Schmidt, J. & Dalakas, M.C., 2007. Upregulation Of 
Thrombospondin-1(Tsp-1) And Its Binding Partners, Cd36 And Cd47, In Sporadic 
Inclusion Body Myositis. Journal Of Neuroimmunology, 187, 166-174. 
Sinkler, S.Y. & Segal, S.S., 2014. Aging Alters Reactivity Of Microvascular Resistance 
Networks In Mouse Gluteus Maximus Muscle. American Journal Of Physiology-
Heart And Circulatory Physiology, 307, H830-H839. 
Smadja, D.M., D'audigier, C., Bieche, I., Evrard, S., Mauge, L., Dias, J.V., Labreuche, J., 
Laurendeau, I., Marsac, B., Dizier, B., Wagner-Ballon, O., Boisson-Vidal, C., 
Morandi, V., Duong-Van-Huyen, J.P., Bruneval, P., Dignat-George, F., Emmerich, 
J. & Gaussem, P., 2011. Thrombospondin-1 Is A Plasmatic Marker Of Peripheral 
Arterial Disease That Modulates Endothelial Progenitor Cell Angiogenic 
Properties. Arteriosclerosis Thrombosis And Vascular Biology, 31, 551-559. 
Stapleton, P.A., Abukabda, A.B., Hardy, S.L. & Nurkiewicz, T.R., 2015a. Xenobiotic 
Pulmonary Exposure And Systemic Cardiovascular Response Via Neurological 
Links. American Journal Of Physiology-Heart And Circulatory Physiology, 309, 
H1609-H1620. 
Stapleton, P.A., Mcbride, C.R., Yi, J. & Nurkiewicz, T.R., 2015b. Uterine Microvascular 
Sensitivity To Nanomaterial Inhalation: An In Vivo Assessment. Toxicology And 
Applied Pharmacology, 288, 420-428. 
Stapleton, P.A., Minarchick, V.C., Cumpston, A.M., Mckinney, W., Chen, B.T., Sager, 
T.M., Frazer, D.G., Mercer, R.R., Scabilloni, J., Andrew, M.E., Castranova, V. & 
Nurkiewicz, T.R., 2012. Impairment Of Coronary Arteriolar Endothelium-
Dependent Dilation After Multi-Walled Carbon Nanotube Inhalation: A Time-
Course Study. International Journal Of Molecular Sciences, 13, 13781-13803. 
Stenina, O.I., Krukovets, I., Wang, K., Zhou, Z.M., Forudi, F., Penn, M.S., Topol, E.J. & 
Plow, E.F., 2003. Increased Expression Of Thrombospondin-1 In Vessel Wall Of 
Diabetic Zucker Rat. Circulation, 107, 3209-3215. 
Sun, Q.H., Yue, P., Deiuliis, J.A., Lumeng, C.N., Kampfrath, T., Mikolaj, M.B., Cai, Y., 
Ostrowski, M.C., Lu, B., Parthasarathy, S., Brook, R.D., Moffatt-Bruce, S.D., 
Chen, L.C. & Rajagopalan, S., 2009. Ambient Air Pollution Exaggerates Adipose 
Inflammation And Insulin Resistance In A Mouse Model Of Diet-Induced Obesity. 
Circulation, 119, 538-U91. 
Switalska, H.I., Niewiarowski, S., Tuszynski, G.P., Rucinski, B., Schmaier, A.H., Morinelli, 
T.A. & Cierniewski, C.S., 1985. Radioimmunoassay Of Human-Platelet 
Thrombospondin - Different Patterns Of Thrombospondin And Beta-
Thromboglobulin Antigen Secretion And Clearance From The Circulation. Journal 
Of Laboratory And Clinical Medicine, 106, 690-700. 
163 
 
Varma, V., Yao-Borengasser, A., Bodles, A.M., Rasouli, N., Phanavanh, B., Nolen, G.T., 
Kern, E.M., Nagarajan, R., Spencer, H.J., Lee, M.J., Fried, S.K., Mcgehee, R.E., 
Peterson, C.A. & Kern, P.A., 2008. Thrombospondin-1 Is An Adipokine Associated 
With Obesity, Adipose Inflammation, And Insulin Resistance. Diabetes, 57, 432-
439. 
Wang, Y., Xu, Z., Guo, S., Zhang, L., Sharma, A., Robertson, G.P. & Huang, L., 2013. 
Intravenous Delivery Of Sirna Targeting Cd47 Effectively Inhibits Melanoma 
Tumor Growth And Lung Metastasis. Mol Ther, 21, 1919-29. 
Xu, X.H., Rao, X.Q., Wang, T.Y., Jiang, S.Y., Ying, Z.K., Liu, C.Q., Wang, A.X., Zhong, 
M.H., Deiuliis, J.A., Maiseyeu, A., Rajagopalan, S., Lippmann, M., Chen, L.C. & 
Sun, Q.H., 2012. Effect Of Co-Exposure To Nickel And Particulate Matter On 
Insulin Resistance And Mitochondrial Dysfunction In A Mouse Model. Particle And 
Fibre Toxicology, 9. 
Xu, X.H., Yavar, Z.B., Verdin, M., Ying, Z.K., Mihai, G., Kampfrath, T., Wang, A.X., 
Zhong, M.H., Lippmann, M., Chen, L.C., Rajagopalan, S. & Sun, Q.H., 2010. 
Effect Of Early Particulate Air Pollution Exposure On Obesity In Mice Role Of 
P47(Phox). Arteriosclerosis Thrombosis And Vascular Biology, 30, 2518-U357. 
 
 
 
 
 
 
 
 
